Staff Publications Received in April, 2022

1.        Akpan I.N., Taskin T., Wheldon C.W., Rossheim M.E., Thompson E.L., Human papillomavirus vaccination uptake among 27-to-45-year-olds in the United States. Prev Med. 182: 107951, 2024. PMID38604575.

2.        Atkins M.B., Jegede O.A., Haas N.B., McDermott D.F., Bilen M.A., Stein M., Sosman J., Alter R., Plimack E.R., Ornstein M.C., Hurwitz M., Peace D.J., Einstein D., Catalano P.J., Hammers H., Regan M.M., Treatment-free survival outcomes from the phase ii study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (hcrn gu16-260-cohort a). J Immunother Cancer. 12(4)2024. PMID38604810. PMC11015345.

3.        Bagnyukova T., Egleston B.L., Pavlov V.A., Serebriiskii I.G., Golemis E.A., Borghaei H., Synergy of EGFR and AURKA inhibitors in KRAS-mutated non-small cell lung cancers. Cancer Res Commun, 2024. PMID38639476.

4.        Balbach M.L., Neely G., Yorke A., Figueroa-Medina E., Paly J., Shulman R.M., Dempsey C., Shulman A., Biancia C.D., Cutrer W.B., Li B.C., Developing an educational “hub”: Impact of a distance-learning curriculum in a multinational cohort. BMC Med Educ. 24(1): 406, 2024. PMID38610008. PMC11010438.

5.        Bamgbose G., Bordet G., Lodhi N., Tulin A., Mono-methylated histones control parp-1 in chromatin and transcription. Elife. 132024. PMID38690995.

6.        Barata P., Gulati S., Elliott A., Hammers H.J., Burgess E.F., Gartrell B.A., Darabi S., Bilen M.A., Basu A., Geynisman D.M., Dawson N.A., Zibelman M.R., Zhang T., Wei S., Ryan C.J., Heath E.I., Poorman K.A., Nabhan C., McKay R.R., Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles. J Clin Invest, 2024. PMID38652565.

7.        Bremner R.M., Ungerleider R.M., Ungerleider J., Wolf A.S., Erkmen C.P., Luc J.G.Y., Litle V.R., Cerfolio R.J.,Cooke D.T., Well-being of cardiothoracic surgeons in the time of covid-19: A survey by the wellness committee of the American association for thoracic surgery. Semin Thorac Cardiovasc Surg. 36(1): 129-136, 2024. PMID36244627.PMC9561391.

8.        Budagyan K., Cannon A.C., Chernoff J., A facile method to append a bio-id tag to endogenous mutant kras alleles. Methods Mol Biol. 2797: 351-362, 2024. PMID38570472.

9.        Bychkov I., Deneka A., Topchu I., Pangeni R., Ismail A., Lengner C., Karanicolas J., Golemis E., Makhov P., Boumber Y., Musashi-2 (msi2) regulation of DNA damage response in lung cancer. Res Sq, 2024. PMID38659828.PMC11042440. [Preprint]

10.      Carril-Ajuria L., Lavaud P., Dalban C., Negrier S., Gravis G., Motzer R.J., Chevreau C., Tannir N.M., Oudard S., McDermott D.F., Laguerre B., Hammers H.J., Barthelemy P., Plimack E.R., Borchiellini D., Gross-Goupil M., Jiang R., Lee C.W., de Silva H., Rini B.I., Escudier B., Albigès L., Validation of the lung immune prognostic index (lipi) as a prognostic biomarker in metastatic renal cell carcinoma. Eur J Cancer. 204: 114048, 2024. PMID38653033.

11.      Chen-Yost H.I., Bammert C., Hao W., Heymann J.J., Lin D.M., Marotti J., Waraksa-Deutsch T., Huang M., Krishnamurti U., Lin O., Ly A., Moatamed N., Pantanowitz L., Roy-Chowdhuri S., Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023. J Am Soc Cytopathol, 2024. PMID38582697.

12.      Chiba M., Shimono J., Suto K., Ishio T., Endo T., Goto H., Hasegawa H., Maeda M., Teshima T., Yang Y., Nakagawa M., Whole-genome CRISPR screening identifies molecular mechanisms of pd-l1 expression in adult t-cell leukemia/lymphoma. Blood. 143(14): 1379-1390, 2024. PMID38142436. PMC11033594.

13.      Covington E.L., Suresh K., Anderson B.M., Barker M., Dess K., Price J.G., Moncion A., Vaccarelli M.J., Santanam L., Xiao Y., Mayo C., Perceptions on and roadblocks to implementation of standardized nomenclature in radiation oncology: A survey from tg-263u1. J Appl Clin Med Phys: e14359, 2024. PMID38689502.

14.      Ditonno F., Veccia A., Montanaro F., Pettenuzzo G., Franco A., Manfredi C., Triggiani L., De Nunzio C., De Sio M., Cerruto M., Crivellaro S., Kutikov A., Autorino R., Antonelli A.  Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder cancer: A systematic review and meta-analysis of comparative studies. BJU Int, 2024. PMID38622957.

15.      Donovan B., Wiese D., Henry K.A., Wu J., Rae L. ,Anderson J., Evaluating the effects of food deserts and food swamps in an urban burn patient population. J Burn Care Res, 2024. PMID38630546.

16.      Drevik J.A., Dalimov Z., Lucas J., Simhan J., Cohn J.A., Factors associated with postoperative urinary retention in patients undergoing penile prosthesis implantation. Int J Impot Res. 36(3): 201-205, 2024. PMID36198809.

17.      Elkins M., Jain N., Tükel Ç., The menace within: Bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases. Curr Opin Microbiol. 79: 102473, 2024. PMID38608623.

18.      Fried W., Tyagi M., Minakhin L., Chandramouly G., Tredinnick T., Ramanjulu M., Auerbacher W., Calbert M., Rusanov T., Hoang T., Borisonnik N., Betsch R., Krais J.J., Wang Y., Vekariya U.M., Gordon J., Morton G., Kent T., Skorski T., Johnson N., Childers W., Chen X.S., Pomerantz R.T., Discovery of a small-molecule inhibitor that traps polθ on DNA and synergizes with parp inhibitors. Nat Commun. 15(1): 2862, 2024. PMID38580648.PMC10997755.

19.      Gautam A., Boyd D.F., Nikhar S., Zhang T., Siokas I., Van de Velde L.A., Gaevert J., Meliopoulos V., Thapa B., Rodriguez D.A., Cai K.Q., Yin C., Schnepf D., Beer J., DeAntoneo C., Williams R.M., Shubina M., Livingston B., Zhang D., Andrake M.D., Lee S., Boda R., Duddupudi A.L., Crawford J.C., Vogel P., Loch C., Schwemmle M., Fritz L.C., Schultz-Cherry S., Green D.R., Cuny G.D., Thomas P.G., Degterev A., Balachandran S., Necroptosis blockade prevents lung injury in severe influenza. Nature. 628(8009): 835-843, 2024. PMID38600381.

20.      Gerber D.E., Wang Y., Ramalingam S.S., Bhalla S., Sun Z., Borghaei H., Brahmer J.R., Schiller J.H., Incidence, correlates, and prognostic significance of mixed response in advanced non-small cell lung cancer. Oncologist. 29(4): 342-349, 2024. PMID38207008. PMC10994259.

21.      Hall M.J., D’Avanzo P.A., Chertock Y., Kelly P.J.A., Brajuha J., Singley K., Luck C.C., Bass S.B., Oncologists’ perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patients. BMC Cancer. 24(1): 412, 2024. PMID38566032. PMC10988900.

22.      Hayakawa K., Zhou Y., Shinton S.A., B-1 derived anti-thy-1 b cells in old aged mice develop lymphoma/leukemia with high expression of cd11b and hamp2 that different from tcl1 transgenic mice. Immun Ageing. 21(1): 22, 2024. PMID38570827. PMC10988983.

23.      Hayek H., Rehbini O., Kosmider B., Brandt T., Chatila W., Marchetti N., Criner G.J., Bolla S., Kishore R., Bowler R.P., Bahmed K., The regulation of fatty acid synthase by exosomal mir-143-5p and mir-342-5p in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 70(4): 259-282, 2024. PMID38117249.

24.      Hildebrand E.M., Polovnikov K., Dekker B., Liu Y., Lafontaine D.L., Fox A.N., Li Y., Venev S.V., Mirny L.A., Dekker J., Mitotic chromosomes are self-entangled and disentangle through a topoisomerase-ii-dependent two-stage exit from mitosis. Mol Cell. 84(8): 1422-1441.e14, 2024. PMID38521067.

25.      Hussen A.S., Kravitz H.L., Freudenthal B.D., Whitaker A.M., Oxidative DNA damage on the VEGF G-quadruplex forming promoter is repaired via long-patch BER. Environ Mol Mutagen. 65 Suppl 1(Suppl 1): 25-39, 2024. PMID37606505. PMC10984112.

26.      Im E.O., Chee W., Paul S., Choi M.Y., Kim S.Y., Yeo S., Ulrich C.M., Schapira M.M., Nguyen G.T., Meghani S., Mao J.J., Ma G., Inouye J., Deatrick J.A., Shin D., Bao T.  Five dimensions of needs for help: The efficacy of a technology-based intervention among Asian American breast cancer survivors. J Cancer Educ, 2024. PMID38594385.

27.      Ioffe D., McSweeny M., Hall M.J., Precision medicine in the era of genetic testing: Microsatellite instability evolved. Clin Colon Rectal Surg. 37(3): 157-171, 2024. PMID38617845. PMC11007599.

28.      Jain S., Bakolitsa C., Brenner S.E., Radivojac P., Moult J., Repo S., Hoskins R.A., Andreoletti G., Barsky D., Chellapan A., Chu H.Y., Dabbiru N., Kollipara N.K., Ly M., Neumann A.J., Pal L.R., Odell E., Pandey G., Peters-Petrulewicz R.C., Srinivasan R., Yee S.F., Yeleswarapu S.J., Zuhl M., Adebali O., Patra A., Beer M.A., Hosur R., Peng J., Bernard B.M., Berry M., Dong S.C., Boyle A.P., Adhikari A., Chen J.Q., Hu Z.Q., Wang R., Wang Y.Q., Miller M., Wang Y.R., Bromberg Y., Turina P., Capriotti E., Han J.J., Ozturk K., Carter H., Babbi G., Bovo S., Di Lena P., Martelli P.L., Savojardo C., Casadio R., Cline M.S., De Baets G., Bonache S., Díez O., Gutiérrez-Enríquez S., Fernández A., Montalban G., Ootes L., Özkan S., Padilla N., Riera C., De la Cruz X., Diekhans M., Huwe P.J., Wei Q., Xu Q.F., Dunbrack R.L., Gotea V., Elnitski L., Margolin G., Fariselli P., Kulakovskiy I.V., Makeev V.J., Penzar D.D., Vorontsov I.E., Favorov A.V., Forman J.R., Hasenahuer M., Fornasari M.S., Parisi G., Avsec Z., Celik M.H., Nguyen T.Y.D., Gagneur J., Shi F.Y., Edwards M.D., Guo Y.C., Tian K., Zeng H.Y., Gifford D.K., Göke J., Zaucha J., Gough J., Ritchie G.R.S., Frankish A., Mudge J.M., Harrow J., Young E.L., Yu Y., Huff C.D., Murakami K., Nagai Y., Imanishi T., Mungall C.J., Jacobsen J.O.B., Kim D., Jeong C.S., Jones D.T., Li M.J., Guthrie V.B., Bhattacharya R., Chen Y.C., Douville C., Fan J., Kim D., Masica D., Niknafs N., Sengupta S., Tokheim C., Turner T.N., Yeo H.T.G., Karchin R., Shin S., Welch R., Keles S., Li Y., Kellis M., Corbi-Verge C., Strokach A.V., Kim P.M., Klein T.E., Mohan R., Sinnott-Armstrong N.A., Wainberg M., Kundaje A., Gonzaludo N., Mak A.C.Y., Chhibber A., Lam H.Y.K., Dahary D., Fishilevich S., Lancet D., Lee I., Bachman B., Katsonis P., Lua R.C., Wilson S.J., Lichtarge O., Bhat R.R., Sundaram L., Viswanath V., Bellazzi R., Nicora G., Rizzo E., Limongelli I., Mezlini A.M., Chang R., Kim S., Lai C., O’Connor R., Topper S., van den Akker J., Zhou A.Y., Zimmer A.D., Mishne G., Bergquist T.R., Breese M.R., Guerrero R.F., Jiang Y.X., Kiga N., Li B., Mort M., Pagel K.A., Pejaver V., Stamboulian M.H., Thusberg J., Mooney S.D., Teerakulkittipong N., Cao C., Kundu K., Yin Y.Z., Yu C.H., Kleyman M., Lin C.F., Stackpole M., Mount S.M., Eraslan G., Mueller N.S., Naito T., Rao A.R., Azaria J.R., Brodie A., Ofran Y., Garg A., Pal D., Hawkins-Hooker A., Kenlay H., Reid J., Mucaki E.J., Rogan P.K., Schwarz J.M., Searls D.B., Lee G.R., Seok C., Kramer A., Shah S., Huang C.V., Kirsch J.F., Shatsky M., Cao Y., Chen H.R., Karimi M., Moronfoye O., Sun Y.F., Shen Y., Shigeta R., Ford C.T., Nodzak C., Uppal A., Shi X.H., Joseph T., Kotte S., Rana S., Rao A., Saipradeep V.G., Sivadasan N., Sunderam U., Stanke M., Su A., Adzhubey I., Jordan D.M., Sunyaev S., Rousseau F., Schymkowitz J., Van Durme J., Tavtigian S.V., Carraro M., Giollo M., Tosatto S.C.E., Adato O., Carmel L., Cohen N.E., Fenesh I., Holtzer I., Juven-Gershon T., Unger R., Niroula A., Olatubosun A., Valiaho J., Yang Y., Vihinen M., Wahl M.E., Chang B., Chong K.C., Hu I., Sun R., Wu W.K.K., Xia X.X., Zee B.C., Wang M.H., Wang M., Wu C.L., Lu Y.T., Chen K., Yang Y.D., Yates C.M., Kreimer A., Yan Z.X., Yosef N., Zhao H.Y., Wei Z.P., Yao Z.M., Zhou F.F., Folkman L., Zhou Y.Q., Daneshjou R., Altman R.B., Inoue F., Ahituv N., Arkin A.P., Lovisa F., Bonvini P., Bowdin S., Gianni S., Mantuano E., Minicozzi V., Novak L., Pasquo A., Pastore A., Petrosino M., Puglisi R., Toto A., Veneziano L., Chiaraluce R., Ball M.P., Bobe J.R., Church G.M., Consalvi V., Mort M., Cooper D.N., Buckley B.A., Sheridan M.B., Cutting G.R., Scaini M.C., Cygan K.J., Fredericks A.M., Glidden D.T., Neil C., Rhine C.L., Fairbrother W.G., Alontaga A.Y., Fenton A.W., Matreyek K.A., Starita L.M., Fowler D.M., Löscher B.S., Franke A., Adamson S.I., Graveley B.R., Gray J.W., Malloy M.J., Kane J.P., Kousi M., Katsanis N., Schubach M., Kircher M., Tang P.L.F., Kwok P.Y., Lathrop R.H., Clark W.T., Yu G.Y.K., LeBowitz J.H., Benedicenti F., Bettella E., Bigoni S., Cesca F., Mammi I., Marino-Bus-Ije C., Milani D., Peron A., Polli R., Sartori S., Stanzial F., Ioldo I., Turolla L., Aspromonte M.C., Bellini M., Leonardi E., Liu X.M., Marshall C., McCombie W.R., Elefanti L., Menin C., Meyn M.S., Murgia A., Nadeau K.C.Y., Neuhausen S.L., Nussbaum R.L., Pirooznia M., Potash J.B., Dimster-Denk D.F., Rine J.D., Sanford J.R., Snyder M., Tavtigian S.V., Cole A.G., Sun S., Verby M.W., Weile J., Roth F.P., Tewhey R., Sabeti P.C., Campagna J., Refaat M.M., Wojciak J., Grubb S., Schmitt N., Shendure J., Spurdle A.B., Stavropoulos D.J., Walton N.A., Zandi P.P., Ziv E., Burke W., Chen F., Carr L.R., Martinez S., Paik J., Harris-Wai J., Yarborough M., Fullerton S.M., Koenig B.A., McInnes G., Shigaki D., Chandonia J.M., Furutsuki M., Kasak L., Yu C.H., Chen R., Cline M.S., Pandey G., Friedberg I., Getz G.A., Cong Q., Kinch L.N., Zhang J., Grishin N.V., Voskanian A., Kann M.G., Clark W.T., Tran E., Ioannidis N.M., Hunter J.M., Udani R., Cai B.H., Morgan A.A., Sokolov A., Stuart J.M., Tavtigian S.V., Minervini G., Monzon A.M., Batzoglou S., Butte A.J., Church G.M., Greenblatt M.S., Hart R.K., Hernandez R., Hubbard T.J.P., Kahn S., O’Donnell-Luria A., Ng P.C., Shon J., Tavtigian S.V., Veltman J., Zook J.M.,Critical Assessment G., Cagi, the critical assessment of genome interpretation, establishes progress and prospects for computational genetic variant interpretation methods. Genome Biology. 25(1): 53, 2024. PMC10882881.

29.      Jermakowicz A.M., Kurimchak A.M., Johnson K.J., Bourgain-Guglielmetti F., Kaeppeli S., Affer M., Pradhyumnan H., Suter R.K., Walters W., Cepero M., Duncan J.S., Ayad N.G., RAPID resistance to bet inhibitors is mediated by FGFR1 in glioblastoma. Sci Rep. 14(1): 9284, 2024. PMID38654040.PMC11039727.

30.      Jog A., Strauss Starling A.L., Kaur I., Um K., Keele L.J., Triggs J.R., Altieri M.S., Shao J.M., Paraesophageal hernia recurrence following repair: Making the case for reoperative surgery in a propensity-matched cohort. Surg Endosc, 2024. PMID38627258.

31.      Johnson N., Surviving without brca2: Mlh1 gets r-looped in to curtail genomic instability. Journal of Clinical Investigation. 134(7)2024.  WOS:001198702600004. PMC10977974.

32.      Kadariya Y., Sementino E., Ruan M., Cheung M., Hadikhani P., Osmanbeyoglu H.U., Klein-Szanto A.J., Cai K.,Testa J.R., Low exposures to amphibole or serpentine asbestos in germline bap1-mutant mice induce mesothelioma characterized by an immunosuppressive tumor microenvironment. Cancer Res Commun. 4(4): 1004-1015, 2024. PMID38592450. PMC11000687.

33.      Kakish H., Sun J., Ammori J.B., Hoehn R.S., Rothermel L.D., First-line immunotherapy for metastatic merkel cell carcinoma: Analysis of real-world survival data and practice patterns. Am J Clin Oncol, 2024. PMID38587336.

34.      Lu Q., Kou D., Lou S., Ashrafizadeh M., Aref A.R., Canadas I., Tian Y., Niu X., Wang Y., Torabian P., Wang L., Sethi G., Tergaonkar V., Tay F., Yuan Z., Han P., Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy. J Hematol Oncol. 17(1): 16, 2024. PMID38566199. PMC10986145.

35.      Mischley V., Maier J., Chen J., Karanicolas J., Ppiscreenml: Structure-based screening for protein-protein interactions using alphafold. bioRxiv 2024. PMID38559274. PMC10979958. [Preprint]

36.      Neal J.W., Minichiello K., Brennick R., Huang R.S.P., Hiemenz M.C., Amler C., Patel J., Herbst R., Reckamp K.L., Borghaei H., Highleyman L., Redman M.W., Pasquina L.W., Kozono D.E., A process to reanalyze clinical DNA sequencing data for biomarker matching in the lung-map master protocol. Oncologist, 2024. PMID38597608.

37.      Nguyen T., Carrieri F.A., Connis N., Lafargue A., Chang J., Chan A., Shetty A.C., Song Y., Hoang T., Jagtap S., Chowdhury D.D., Khan M.A., Gabrielson K.L., Rezaee M., Torres-Ayuso P., Brognard J., Hann C.L., Tran P.T., TNIK inhibition sensitizes TNIK-overexpressing lung squamous cell carcinoma to radiotherapy. Mol Cancer Ther, 2024. PMID38670554.

38.      Punjabi A., Araya S., Amadio G., Webster T., Mutyala S., Wu M., Zhao H., Roth S., Walchak A., Patel S.A., Chimeric versus multiple flaps for composite oral cavity defects: A systematic review and meta-analysis. Laryngoscope, 2024. PMID38689522.

39.      Purdue M.P., Dutta D., Machiela M.J., Gorman B.R., Winter T., Okuhara D., Cleland S., Ferreiro-Iglesias A., Scheet P., Liu A., Wu C., Antwi S.O., Larkin J., Zequi S.C., Sun M., Hikino K., Hajiran A., Lawson K.A., Cárcano F., Blanchet O., Shuch B., Nepple K.G., Margue G., Sundi D., Diver W.R., Folgueira M., van Bokhoven A., Neffa F., Brown K.M., Hofmann J.N., Rhee J., Yeager M., Cole N.R., Hicks B.D., Manning M.R., Hutchinson A.A., Rothman N., Huang W.Y., Linehan W.M., Lori A., Ferragu M., Zidane-Marinnes M., Serrano S.V., Magnabosco W.J., Vilas A., Decia R., Carusso F., Graham L.S., Anderson K., Bilen M.A., Arciero C., Pellegrin I., Ricard S., Scelo G., Banks R.E., Vasudev N.S., Soomro N., Stewart G.D., Adeyoju A., Bromage S., Hrouda D., Gibbons N., Patel P., Sullivan M., Protheroe A., Nugent F.I., Fournier M.J., Zhang X., Martin L.J., Komisarenko M., Eisen T., Cunningham S.A., Connolly D.C., Uzzo R.G., Zaridze D., Mukeria A., Holcatova I., Hornakova A., Foretova L., Janout V., Mates D., Jinga V., Rascu S., Mijuskovic M., Savic S., Milosavljevic S., Gaborieau V., Abedi-Ardekani B., McKay J., Johansson M., Phouthavongsy L., Hayman L., Li J., Lungu I., Bezerra S.M., Souza A.G., Sares C.T.G., Reis R.B., Gallucci F.P., Cordeiro M.D., Pomerantz M., Lee G.M., Freedman M.L., Jeong A., Greenberg S.E., Sanchez A., Thompson R.H., Sharma V., Thiel D.D., Ball C.T., Abreu D., Lam E.T., Nahas W.C., Master V.A., Patel A.V., Bernhard J.C., Freedman N.D., Bigot P., Reis R.M., Colli L.M., Finelli A., Manley B.J., Terao C., Choueiri T.K., Carraro D.M., Houlston R., Eckel-Passow J.E., Abbosh P.H., Ganna A., Brennan P., Gu J.,Chanock S.J., Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet, 2024. PMID38671320.

(Read the NIH news release here: https://www.nih.gov/news-events/news-releases/analysis-identifies-50-new-genomic-regions-associated-kidney-cancer-risk

40.      Quinteros S.L., Snyder N.W., Chatoff A., Ryan F., O’Brien B.,Donnelly S., The helminth-derived peptide, fhhdm-1, reverses the trained phenotype of nod bone-marrow-derived macrophages and regulates proinflammatory responses. Eur J Immunol: e2350643, 2024. PMID38581085.

41.      Reese J.B., Bauman J.R., Sorice K.A., Frederick N., Bober S.L., Reply to S.S. Coughlin et al. JCO Oncol Pract: Op2400202, 2024. PMID38608216.

42.      Rodrigues G., Higgins K.A., Rimner A., Amini A., Chang J.Y., Chun S.G., Donington J., Edelman M.J., Gubens M.A., Iyengar P., Movsas B., Ning M.S., Park H.S., Wolf A., Simone C.B., 2nd, American radium society appropriate use criteria for unresectable locally advanced non-small cell lung cancer. JAMA Oncol, 2024. PMID38602670.

43.      Rodriguez A.L., Cappelletti L., Kurian S.M., Passio C., Rux S. Transitional care navigation. Semin Oncol Nurs. 40(2): 151580, 2024. PMID38290928.

44.      Sadeghi J.K., Reza J.A., Miller C., Cooke D.T., Erkmen C., Death by a thousand delays. JTCVS Open. 18: 353-359, 2024. PMID38690410. PMC11056460.

45.      Sedrak M.S., Sun C.L., Bae M., Freedman R.A., Magnuson A., O’Connor T., Moy B., Wildes T.M., Klepin H.D., Chapman A.E., Tew W.P., Dotan E., Fenton M.A., Kim H., Katheria V., Muss H.B., Cohen H.J., Gross C.P., Ji J., Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: Results from the hurria older patients (hope) prospective study. J Cancer Surviv, 2024. PMID38678525.

46.      Siminoff L.A., Wilson-Genderson M., Chwistek M.,Thomson M., The cancer caregiving burden trajectory over time: Varying experiences of perceived versus objectively measured burden. Oncologist, 2024. PMID38652165.

47.      Skiendzielewski K., Forke C.M., Sarwer D.B., Noll J.G., Wheeler D.C., Henry K.A., Schroeder K., The intersection of adverse childhood experiences and neighborhood determinants of health: An exploratory spatial analysis. Psychol Trauma. 16(Suppl 1): S125-s132, 2024. PMID35834220. PMC9839886.

48.      Stutzmann G.E., Soboloff J.  Channelling calcium signals to therapeutics. J Physiol. 602(8): 1445-1447, 2024. PMID38578234.

49.      Tangudu N.K., Buj R., Wang H., Wang J., Cole A.R., Uboveja A., Fang R., Amalric A., Yang B., Chatoff A., Crispim C.V., Sajjakulnukit P., Lyons M.A., Cooper K., Hempel N., Lyssiotis C.A., Chandran U.R., Snyder N.W., Aird K.M., De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression. Cancer Res Commun, 2024. PMID38626341.

50.      Thomas K.K., Francescatti A.B., Vreeland T.J., Teshome M.K., Morris A.M., Hunt K.K., Katz M.H.G., Villano A.M., Correction: Standardization of colon resection for cancer: An overview of the American College of Surgeons commission on cancer standard 5.6. Ann Surg Oncol, 2024. PMID38662097.

51.      Tiger Y.K.R., Jain S., Barta S.K., Tolu S., Estrella B., Sawas A., Lue J.K., Francescone M.M., Pro B., Amengual J.E., Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature t-cell lymphoma. Leukemia & Lymphoma: 1-10, 2024. WOS:001189458100001.

52.      Wasik M.A., Kim P.M., Nejati R. Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: Pathogenetic insights and translational implications. Front Oncol. 14: 1383741, 2024. PMID38638855. PMC11024630.

53.      Wei S., Pei J., Belser P., Lee T., Farma J.M., Patchefsky A.S., Flieder D.B., Montgomery E.A., Novel mir143hg::Plag1 gene fusion identified in a rectal myxoid leiomyosarcoma. Genes Chromosomes Cancer. 63(4): e23239, 2024. PMID38656544.

54.      Wheldon C.W., Skurka C., Eng N., Inoculating Black/African American and LGBTQ communities against the tobacco industry: The role of community connectedness and tobacco denormalization beliefs. Health Promot Pract. 25(3): 445-454, 2024. PMID36648060.

55.      Xiang A., Braun A.E., Chang C., Swerdloff D., Gross M.S., Simhan J., Penoscrotal inflatable penile prosthesis recipients often fully recover from pain at two weeks following placement. Int J Impot Res, 2024. PMID38561424.

56.      Yang S., Li Y., Wheldon C.W., Prosperi M., George T.J., Shenkman E.A., Wang F., Bian J.,Guo Y., The burden of cancer and pre-cancerous conditions among transgender individuals in a large healthcare network. medRxiv, 2024. PMID38585849. PMC10996763. [Preprint]

57.      Yankey H., Ruth K.J., Dotan E., Reddy S., Meyer J.E., Survival and toxicity in patients with unresectable or inoperable biliary tract cancers with ablative radiation therapy versus nonablative chemoradiation. Advances in Radiation Oncology. 9(4)2024. WOS:001188630500001.

58.      Zarrabi K.K., Miron B., Geynisman D.M., Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the javelin bladder 100 comprehensive clinical subgroup analyses. Transl Androl Urol. 13(3): 463-466, 2024. PMID38590958. PMC10999025.

59.      Zhao J., Reese J.B., Han X., Yabroff K.R. Loneliness and mortality risk among cancer survivors in the United States: A retrospective, longitudinal study. J Natl Compr Canc Netw: 1-5, 2024. PMID38663443.

New Fox Chase Research Profiles

The Talbot Research Library is excited to share with you our latest project.  The Fox Chase Research Profiles!  The research profiles were created by the library using Elsevier’s Pure System..

The Fox Chase Research Profiles gathers and showcases the work done by Fox Chase and Temple cancer center members.  It displays information about researchers, their publications, prizes, and media associated with their work.  It also displays the connections between researchers and the outside scientific community.

It is a powerful tool to help promote and foster research connections by aggregating information on researchers, research units and resources, and their research outputs. 

You can search and interact with our research profiles on our Pure Portal.  We also have a guide for researchers with profiles who want to edit and enhance their own profiles.

Learn More

• Fox Chase Research Profiles
• The Pure Portal (research profiles) Subject Guide

Staff Publications Received in March, 2024

1.        Abu-Rustum N.R., Yashar C.M., Arend R., Barber E., Bradley K., Brooks R., Campos S.M., Chino J., Chon H.S., Crispens M.A., Damast S., Fisher C.M., Frederick P., Gaffney D.K., Gaillard S., Giuntoli R., II, Glaser S., Holmes J., Howitt B.E., Kendra K., Lea J., Lee N., Mantia-Smaldone G., Mariani A., Mutch D., Nagel C., Nekhlyudov L., Podoll M., Rodabaugh K., Salani R., Schorge J., Siedel J., Sisodia R., Soliman P., Ueda S., Urban R., Wethington S.L., Wyse E., Zanotti K., McMillian N.,Espinosa S., Vulvar cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 22(2): 117-135, 2024. PMID38503056.

2.        Anderson E.C., DiPalazzo J., Lucas F.L., Hall M.J., Antov A., Helbig P., Bourne J., Graham L., Gaitor L., Lu-Emerson C., Bradford L.S., Inhorn R., Sinclair S.J., Brooks P.L., Thomas C.A., Rasmussen K., Han P.K.J., Liu E.T., Rueter J., Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (mcgi). NPJ Precis Oncol. 8(1): 67, 2024. PMID38461318. PMC10924947.

3.        Barham D.W., Pyrgidis N., Amini E., Hammad M., Miller J., Andrianne R., Burnett A.L., Gross K., Hatzichristodoulou G., Hotaling J., Hsieh T.C., Jenkins L.C., Jones J.M., Lentz A., Modgil V., Osmonov D., Park S.H., Pearce I., Perito P., Sadeghi-Nejad H., Sempels M., Suarez-Sarmiento A., Simhan J., van Renterghem K., Warner J.N., Ziegelmann M., Yafi F.A., Gross M.S., Does climate impact inflatable penile prosthesis infection (ipp) risk? Assessment of temperature and dew point on ipp infections. J Sex Med, 2024. PMID38481017.

4.        Barnes D.R., Tyrer J.P., Dennis J., Leslie G., Bolla M.K., Lush M., Aeilts A.M., Aittomäki K., Andrieu N., Andrulis I.L., Anton-Culver H., Arason A., Arun B.K., Balmaña J., Bandera E.V., Barkardottir R.B., Berger L.P.V., de Gonzalez A.B., Berthet P., Białkowska K., Bjørge L., Blanco A.M., Blok M.J., Bobolis K.A., Bogdanova N.V., Brenton J.D., Butz H., Buys S.S., Caligo M.A., Campbell I., Castillo C., Claes K.B.M., Colonna S.V., Cook L.S., Daly M.B., Dansonka-Mieszkowska A., de la Hoya M., deFazio A., DePersia A., Ding Y.C., Domchek S.M., Dörk T., Einbeigi Z., Engel C., Evans D.G., Foretova L., Fortner R.T., Fostira F., Foti M.C., Friedman E., Frone M.N., Ganz P.A., Gentry-Maharaj A., Glendon G., Godwin A.K., González-Neira A., Greene M.H., Gronwald J., Guerrieri-Gonzaga A., Hamann U., Hansen T.V.O., Harris H.R., Hauke J., Heitz F., Hogervorst F.B.L., Hooning M.J., Hopper J.L., Huff C.D., Huntsman D.G., Imyanitov E.N., Izatt L., Jakubowska A., James P.A., Janavicius R., John E.M., Kar S., Karlan B.Y., Kennedy C.J., Kiemeney L., Konstantopoulou I., Kupryjanczyk J., Laitman Y., Lavie O., Lawrenson K., Lester J., Lesueur F., Lopez-Pleguezuelos C., Mai P.L., Manoukian S., May T., McNeish I.A., Menon U., Milne R.L., Modugno F., Mongiovi J.M., Montagna M., Moysich K.B., Neuhausen S.L., Nielsen F.C., Noguès C., Oláh E., Olopade O.I., Osorio A., Papi L., Pathak H., Pearce C.L., Pedersen I.S., Peixoto A., Pejovic T., Peng P.C., Peshkin B.N., Peterlongo P., Powell C.B., Prokofyeva D., Pujana M.A., Radice P., Rashid M.U., Rennert G., Richenberg G., Sandler D.P., Sasamoto N., Setiawan V.W., Sharma P., Sieh W., Singer C.F., Snape K., Sokolenko A.P., Soucy P., Southey M.C., Stoppa-Lyonnet D., Sutphen R., Sutter C., Teixeira M.R., Terry K.L., Thomsen L.C.V., Tischkowitz M., Toland A.E., Van Gorp T., Vega A., Velez Edwards D.R., Webb P.M., Weitzel J.N., Wentzensen N., Whittemore A.S., Winham S.J., Wu A.H., Yadav S., Yu Y., Ziogas A., Berchuck A., Couch F.J., Goode E.L., Goodman M.T., Monteiro A.N., Offit K., Ramus S.J., Risch H.A., Schildkraut J.M., Thomassen M., Simard J., Easton D.F., Jones M.R., Chenevix-Trench G., Gayther S.A., Antoniou A.C., Pharoah P.D.P. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. medRxiv, 2024. PMID38496424. PMC10942532. [Preprint]

5.        Beltrán-Visiedo M., Balachandran S., Galluzzi L., Mre11 mobilizes cgas and drives zbp1-dependent necroptosis. Cell Res, 2024. PMID38443562.

6.        Berman E., Shah N.P., Deninger M., Altman J.K., Amaya M., Begna K., Bhatia R., Chan O., Collins R., Curtin P., DeAngelo D.J., Drazer M., Maness L., Metheny L., Mohan S., Moore J., Oehler V., Pratz K., Pusic I., Rose M., Shomali W., Smith B.D., Styler M., Sweet K., Talpaz M., Tanaka T., Tantravahi S., Tsai S., Vaughn J., Welborn J., Yang D., Mauro M., Cortes J., Radich J.,Druker B., CML and the WHO: Why? J Clin Oncol. 42(9): 984-986, 2024. PMID38086008. [Comment]

7.        Budyagan K., Cannon A.C., Chatoff A., Snyder N.W., Kurimchak A.M., Duncan J.S., Chernoff J., Kras mutation-selective requirement for acss2 in colorectal adenoma formation. Res Sq, 2024. PMID38464238. PMC10925460. [Pre-print]

8.        Cannon A.C., Budagyan K., Uribe-Alvarez C., Kurimchak A.M., Araiza-Olivera D., Cai K.Q., Peri S., Zhou Y., Duncan J.S. Chernoff J., Unique vulnerability of rac1-mutant melanoma to combined inhibition of cdk9 and immune checkpoints. Oncogene. 43(10): 729-743, 2024. PMID38243078.

9.        Chen N., McGrath C.B., Ericsson C.I., Vaselkiv J.B., Rencsok E.M., Stopsack K.H., Guard H.E., Autio K.A., Rathkopf D.E., Enting D., Bitting R.L., Mateo J., Githiaka C.W., Chi K.N., Cheng H.H., Davis I.D., Anderson S.G., Badal S.A.M., Bjartell A., Russnes K.M., Heath E.I., Pomerantz M.M., Henegan J.C., Hyslop T., Esteban E., Omlin A., McDermott R., Fay A.P., Popoola A.A., Ragin C., Nowak J., Gerke T., Kantoff P.W., George D.J., Penney K.L.,Mucci L.A., Marital status, living arrangement, and survival among individuals with advanced prostate cancer in the international registry for men with advanced prostate cancer. Cancer Epidemiol Biomarkers Prev. 33(3): 419-425, 2024. PMID38189661. PMC10922505.

10.      Chwistek M. Mitigating the risk of aberrant use of opioids in patients with cancer pain. Journal of the National Comprehensive Cancer Network. 21(11): 1212-1213, 2023. PMIDWOS:001171227400013.

11.      Deni W.H., Gao T., Wu J., Protocol for reconstituting peptides/peptidomimetics from DMSO to aqueous buffers for circular dichroism analyses. STAR Protoc. 5(1): 102850, 2024. PMID38285735. PMC10839526.

12.      Hildebrand E.M., Polovnikov K., Dekker B., Liu Y., Lafontaine D.L., Fox A.N., Li Y., Venev S.V., Mirny L.A., Dekker J., Mitotic chromosomes are self-entangled and disentangle through a topoisomerase-ii-dependent two-stage exit from mitosis. Mol Cell, 2024. PMID38521067.

13.      Hutchings H., Behinaein P., Enofe N., Brue K., Tam S., Chang S., Movsas B., Poisson L., Wang A.,Okereke I., Association of social determinants with patient-reported outcomes in patients with cancer. Cancers (Basel). 16(5)2024. PMID38473374. PMC10930456.

14.      Iyer S.P., Johnston P.B., Barta S.K., Pralatrexate injection combined with CHOP for treatment of PTCL: Results from the Fol-CHOP dose-finding phase 1 trial. Blood Advances. 8(2): 353-364, 2024. WOS:001166650400001.

15.      Johnson C.K., Leung M.M., Ma G.X., Ogunwobi O.O., Effective recruitment strategies utilized to examine dietary practices of Blacks in New York City in the midst of the covid-19 pandemic. J Racial Ethn Health Disparities. 11(2): 764-772, 2024. PMID36929490.PMC10019415.

16.      Juric D., Barve M., Vaishampayan U., Roda D., Calvo A., Jañez N.M., Trigo J., Greystoke A., Harvey R.D., Olszanski A.J., Opyrchal M., Spira A., Thistlethwaite F., Jiménez B., Sappal J.H., Kannan K., Riley J., Li C., Li C., Gregory R.C., Miao H.,Wang S., A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors. Cancer Med. 13(5)2024. PMID38501219. PMC10949085.

17.      Kanefsky J., Basse M., Sokei J., di Martino O., Valin L., Jaspers Y., Martinez E., Huhn J., Di Marcantonio D., Magee J.A., Goldman A.R., Tang H.Y., Ferraro F., Kemp S., Wiest D.L., Sykes S.M., Disruption of polyunsaturated fatty acid biosynthesis drives sting-dependent acute myeloid leukemia cell maturation and death. J Biol Chem: 107214, 2024. PMID38522521.

18.      Klochkova A., Karami A.L., Fuller A.D., Parham L.R., Panchani S.R., Natarajan S., Jackson J.L., Mu A., Tan Y., Cai K.Q., Klein-Szanto A.J., Muir A.B., Tétreault M.P., Graña X., Hamilton K.E., Whelan K.A., Autophagy contributes to homeostasis in esophageal epithelium where high autophagic vesicle level marks basal cells with limited proliferation and enhanced self-renewal potential. Cell Mol Gastroenterol Hepatol, 2024. PMID38452871.

19.      Mell L.K., Pugh S.L., Jones C.U., Nelson T.J., Zakeri K., Rose B.S., Zeitzer K.L., Gore E.M., Bahary J.P., Souhami L., Michalski J.M., Hartford A.C., Mishra M.V., Roach M., 3rd, Parliament M.B., Choi K.N., Pisansky T.M., Husain S.M., Malone S.C., Horwitz E.M., Feng F.  Effects of androgen deprivation therapy on prostate cancer outcomes according to competing event risk: Secondary analysis of a phase 3 randomised trial. Eur Urol. 85(4): 373-381, 2024. PMID36710205.PMC10372191.

20.      Muquith M., Espinoza M., Elliott A., Xiu J., Seeber A., El-Deiry W., Antonarakis E.S., Graff S.L., Hall M.J., Borghaei H., Hoon D.S.B., Liu S.V., Ma P.C., McKay R.R., Wise-Draper T., Marshall J., Sledge G.W., Spetzler D., Zhu H., Hsiehchen D., Tissue-specific thresholds of mutation burden associated with anti-pd-1/l1 therapy benefit and prognosis in microsatellite-stable cancers. Nat Cancer, 2024. PMID38528112.

21.      Murayama T., Nakayama J., Jiang X., Miyata K., Morris A.D., Cai K.Q., Prasad R.M., Ma X., Efimov A., Belani N., Gerstein E.R., Tan Y., Zhou Y., Kim W., Maruyama R., Campbell K.S., Chen L., Yang Y., Balachandran S., Cañadas I., Targeting dhx9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer. Cancer Discov. 14(3): 468-491, 2024. PMID38189443. PMC10905673.

22.      Naia Fioretto M., Colombelli K.T., da Silva C.L.F., Dos Santos S.A.A., Camargo A.C.L., Constantino F.B., Portela L.M.F., Aquino A.M., Barata L.A., Mattos R., Scarano W.R., Zambrano E., Justulin L.A., Maternal malnutrition associated with postnatal sugar consumption increases inflammatory response and prostate disorders in rat offspring. Mol Cell Endocrinol: 112223, 2024. PMID38556160.

23.      Ninmer E.K., Zhu H., Chianese-Bullock K.A., von Mehren M., Haas N.B., Ross M.I., Dengel L.T., Slingluff C.L., Jr.  Multipeptide vaccines for melanoma in the adjuvant setting: Long-term survival outcomes and post-hoc analysis of a randomized phase II trial. Nat Commun. 15(1): 2570, 2024. PMID38519525. PMC10959948.

24.      Omil-Lima D.,Kutikov A. Reply by authors. Urology Practice. 11(1): 48-48, 2024. WOS:001163787500066.

25.      Omil-Lima D., Tracy C.R., Steinberg R.L., Re: Predictors of excellent urology residents at the time of the urology match. Urology, 2024. PMID38518994.

26.      Parikh M., Tangen C., Hussain M.H.A., Gupta S., Callis S., Jo Y., Harzstark A., Paller C.J., George S., Zibelman M.R., Cheng H.H., Maughan B.L., Zhang J., Pachynski R.K., Bryce A.H., Lin D.W., Quinn D.I., Lerner S.P., Thompson I.M., Dorff T.B., Lara P.N., Agarwal N., Three- and seven-month prostate-specific antigen levels as prognostic markers for overall survival in metastatic hormone-sensitive prostate cancer: Results from SWOG s1216, a phase 3 randomized trial of androgen deprivation plus orteronel or bicalutamide. Eur Urol Oncol, 2024. PMID38523017.

27.      Plimack E.R., Powles T., Stus V., Gafanov R., Nosov D., Waddell T., Alekseev B., Pouliot F., Melichar B., Soulières D., Borchiellini D., McDermott R.S., Vynnychenko I., Chang Y.H., Tamada S., Atkins M.B., Molife L.R., Li C.X., Perini R., Bedke J., Rini B.I. Pembrolizumab plus axitinib versus sunitinib as first-line treatment of advanced renal cell carcinoma: 43-month follow-up of the phase 3 keynote-426 study” eur urol 84(5) (2023) 449-454. European Urology. 85(2): e58-e59, 2024. PMIDWOS:001167642100001.

28.      Pratt-Chapman M.L., Tredway K., Wheldon C.W., Streed C.G., Jr., Scout N.F.N., Ose J.,Jackson S.S., Strategies for advancing sexual orientation and gender identity data collection in cancer research. JCO Oncol Pract: Op2300629, 2024. PMID38547426.

29.      Reinhardt M.E., Mutyala S., Gerald M., Zhao H., Nova V., Araya Cambronero S., Patel S., Baltodano P.A., The critical blood-sparing effect of tranexamic acid (txa) in liposuction: A systematic review and meta-analysis. JPRAS Open. 40: 48-58, 2024. PMID38425698. PMC10904189.

30.      Richardson D.L., Moore K.N., Vergote I., Gilbert L., Martin L.P., Mantia-Smaldone G.M., Castro C.M., Provencher D., Matulonis U.A., Stec J., Wang Y., Method M., O’Malley D.M., Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (frα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer. Gynecol Oncol. 185: 186-193, 2024. PMID38447347.

31.      Rini B.I., Plimack E.R., Stus V., Gafanov R., Waddell T., Nosov D., Pouliot F., Alekseev B., Soulieres D., Melichar B., Vynnychenko I.O., Azevedo S.J., Borchiellini D., McDermott R.S., Bedke J., Tamada S., Wu S., Burgents J., Molife L.R.,Powles T., Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma: 5-year analysis of keynote-426. Journal of Clinical Oncology. 41(17_SUPPL): LBA4501-LBA4501, 2023. PMIDWOS:001182783300026.

32.      Ryu Tiger Y.K., Jain S., Barta S.K., Tolu S., Estrella B., Sawas A., Lue J.K., Francescone M.M., Pro B.,Amengual J.E., Phase ii study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature t-cell lymphoma. Leuk Lymphoma: 1-10, 2024. PMID38517235.

33.      Schuetze S.M., Ballman K.V., Heise R., Ganjoo K.N., Davis E.J., George S., Burgess M.A., Choy E., Shepard D.R., Tinoco G., Hirbe A., Kelly C.M., Attia S., Deshpande H.A., Schwartz G.K., Siontis B.L., Riedel R.F., von Mehren M., Kozlowski E., Chen H.X., Astbury C.,Rubin B.P., A single arm phase 2 trial of trametinib in patients with locally advanced or metastatic epithelioid hemangioendothelioma. Clin Cancer Res, 2024. PMID38446990.

34.      Shulman R.M., Deng M., Handorf E.A., Meyer J.E., Lynch S.M.,Arora S., Factors associated with racial and ethnic disparities in locally advanced rectal cancer outcomes. JAMA Netw Open. 7(2): e240044, 2024. PMID38421650. PMC10905315.

35.      Siegel S.D., Zhang Y., Lynch S.M., Rowland J., Curriero F.C. A novel approach for conducting a catchment area analysis of breast cancer by age and stage for a community cancer center. Cancer Epidemiol Biomarkers Prev, 2024. PMID38451180.

36.      Sterling J., Simhan J., Flynn B.J., Rusilko P., França W.A., Ramirez E.A., Angulo J.C., Martins F.E., Patel H.V., Higgins M., Swerdloff D., Nikolavsky D., Multi-institutional outcomes of dorsal onlay buccal mucosal graft urethroplasty in patients with postprostatectomy, postradiation anastomotic stenosis. J Urol. 211(4): 596-604, 2024. PMID38275201.

37.      Stevenson J., Ettinger D.S., Wood D.E., Aisner D.L., Akerley W., Bauman J.R., Bharat A., Bruno D.S., Chang J.Y., Chirieac L.R., DeCamp M., Desai A., Dilling T.J., Dowell J., Durm G.A., Garassino M.C., Gettinger S., Grotz T.E., Gubens M.A., Lackner R.P., Lanuti M., Lin J., Loo B.W., Jr., Lovly C.M., Maldonado F., Massarelli E., Morgensztern D., Mullikin T.C., Ng T., Otterson G.A., Owen D., Patel S.P., Patil T., Polanco P.M., Riely G.J., Riess J., Shapiro T.A., Singh A.P., Tam A., Tanvetyanon T., Yanagawa J., Yang S.C., Yau E., Gregory K., Hang L. Mesothelioma: Pleural, version 1.2024. J Natl Compr Canc Netw. 22(2): 72-81, 2024. PMID38503043.

38.      Sun L., Handorf E.A., Zhou Y., Borghaei H., Aggarwal C., Bauman J. Outcomes in patients treated with frontline immune checkpoint inhibition (ici) for advanced nsclc with kras mutations and stk11/keap1 comutations across pd-l1 levels. Lung Cancer. 190: 107510, 2024. PMID38432028.

39.      Thompson C.L., Buchanan A.H., Myers R., Weinberg D.S., Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials. Front Oncol. 13: 1307459, 2023. PMID38486933. PMC10937460.

40.      Topchu I., Bychkov I., Roshchina E., Makhov P., Boumber Y. Pip4k2b protein regulation by nsd1 in hpv-negative head and neck squamous cell carcinoma. Cancers (Basel). 16(6)2024. PMID38539515. PMC10968846.

41.      Tseng M., Walton E., Egleston B.L., Fang C.Y., Pandemic effects on social capital in residents and non-residents of Chinese immigrant enclaves in Philadelphia. Wellbeing Space and Society. 62024. WOS:001175379900001.

42.      Weinberg D.S., Barkun A., Liquid biopsy for colorectal cancer screening: Not so bloody fast. Gastroenterology, 2024. PMID38555972.

43.      Whitehead R.A., Patel E.A., Liu J.C., Bhayani M.K. Racial disparities in head and neck cancer: It’s not just about access. Otolaryngol Head Neck Surg. 170(4): 1032-1044, 2024. PMID38258967.

44.      Xirou V., Moutafi M., Bai Y., Nwe Aung T., Burela S., Liu M., Kimple R.J., Shabbir Ahmed F., Schultz B., Flieder D., Connolly D.C., Psyrri A., Burtness B., Rimm D.L. An algorithm for standardization of tumor infiltrating lymphocyte evaluation in head and neck cancers. Oral Oncol. 152: 106750, 2024. PMID38547779.

45.      Yang J.Y., Liu C., Deng W.Y., Wu D., Weng C.H., Zhou Y.Y., Wang K., Enhancing phenotype recognition in clinical notes using large language models: Phenobcbert and phenogpt. Patterns. 5(1)2024. WOS:001165274200001.

Staff Publications Received in February, 2024

1.         Ajmal N., Lallas C.D., McCue P., Li L., Succinate dehydrogenase deficient renal cell carcinoma with sarcomatoid and rhabdoid features-a diagnostic dilemma. Int J Surg Pathol: 10668969241229333, 2024. PMID38311902.

2.         Arai H., Yang Y., Baca Y., Millstein J., Denda T., Ou F.S., Innocenti F., Takeda H., Kubota Y., Doi A., Horie Y., Umemoto K., Izawa N., Wang J., Battaglin F., Jayachandran P., Algaze S., Soni S., Zhang W., Goldberg R.M., Hall M.J., Scott A.J., Hwang J.J., Lou E., Weinberg B.A., Marshall J., Goel S., Xiu J., Michael Korn W., Venook A.P., Sunakawa Y.,Lenz H.J., Predictive value of cdc37 gene expression for targeted therapy in metastatic colorectal cancer. Eur J Cancer. 201: 113914, 2024. PMID38359495.

3.         Araya S., Chang A.H., Moss C., Gubara S.M., Gebreyesus M.T., Jordan K., Ruth K.J., Baltodano P., Patel S.A. Contemporary prophylactic antibiotic practices and adjunct therapies in autologous fat grafting procedures: A survey of the aesthetic society members. Aesthetic Surgery Journal Open Forum. 62024. WOS:001157816200001.

4.         Bai Y., Zhang X., Li Y., Qi F., Liu C., Ai X., Tang M., Szeto C., Gao E., Hua X., Xie M., Wang X., Tian Y., Chen Y., Huang G., Zhang J., Xiao W., Zhang L., Liu X., Yang Q., Houser S.R., Chen X., Protein kinase a is a master regulator of physiological and pathological cardiac hypertrophy. Circ Res. 134(4): 393-410, 2024. PMID38275112.

5.         Bartel M.J. Endoscopic resection of t1 colorectal cancer with unfavorable histologic features: What shall we do next? Gastrointest Endosc. 99(3): 417-418, 2024. PMID38368043.Editorial.

6.         Beckermann K.E., Bestvina C.M., El Osta B., Sanborn R.E., Borghaei H., Lammers P.E., Selvaggi G., Whisenant J.G., Heimann-Nichols E., Berry L., Hsu C.Y., Shyr Y., Horn L., Wakelee H. A phase 1/2 study to evaluate the safety and activity of nivolumab in combination with vorolanib, a vascular endothelial growth factor tyrosine kinase inhibitor, in patients with refractory thoracic tumors. JTO Clin Res Rep. 5(2): 100619, 2024. PMID38328473.PMC10847019.

7.         Begum T.F., Patil V.S., Zhu L., Yeh M.C., González E., Fraser M.A., Lu W.Y., Zhu S., Rubio-Torio N., Ma G.X., Tan Y.  Assessing physicians’ recommendations for hepatitis b virus (hbv) and hepatitis c virus (hcv) testing among minority populations in greater Philadelphia and New York City. Journal of Community Health, 2024. WOS:001150463000001.

8.         Bukavina L., Davis L., Helstrom E., Magee D., Ponsky L., Uzzo R., Calaway A., Abbosh P., Kutikov A., Population estimates of ovarian cancer risk in a cohort of patients with bladder cancer. Eur Urol Focus, 2024. PMID38326120.

9.         Chen J., Bearz A., Kim D.W., Mamdani H., Bauman J., Chiari R., Ou S.I., Solomon B.J., Soo R.A., Felip E., Shaw A.T., Thurm H., Clancy J.S., Lee K., O’Gorman M., Tanski C., Pithavala Y.K., Evaluation of the effect of lorlatinib on cyp2b6, cyp2c9, ugt, and p-glycoprotein substrates in patients with advanced non-small cell lung cancer. Clin Pharmacokinet. 63(2): 171-182, 2024. PMID38079095.PMC10847213.

10.       Chioccioli M., Liu S., Magruder S., Tata A., Borriello L., McDonough J.E., Konkimalla A., Kim S.H., Nouws J., Gonzalez D.G., Traub B., Ye X., Yang T., Entenberg D.R., Krishnaswamy S., Hendry C.E., Kaminski N., Tata P.R., Sauler M. Stem cell migration drives lung repair in living mice. Dev Cell, 2024. PMID38377991.

11.       Clarke L.M., Jones R.M., Hiremath S.V., Franklin C., Wright W.G., Tucker C.A. The effects of age and height on gait smoothness in adolescent athletes. Children (Basel). 11(2)2024. PMID38397335.PMC10887815.

12.       D’Avella C., Whooley P., Milano E., Egleston B., Helstrom J., Patrick K., Edelman M., Bauman J. The impact of an oncology urgent care center on healthcare utilization. JNCI Cancer Spectr, 2024. PMID38377387.

13.       Dotan E., Lynch S.M., Ryan J.C., Mitchell E.P. Disparities in care of older adults of color with cancer: A narrative review. Cancer Medicine, 2024. WOS:001143858100001.

14.       Emiloju O.E., Yin J., Koubek E., Reid J.M., Borad M.J., Lou Y., Seetharam M., Edelman M.J., Sausville E.A., Jiang Y., Kaseb A.O., Posey J.A., Davis S.L., Gores G.J., Roberts L.R., Takebe N., Schwartz G.K., Hendrickson A.E.W., Kaufmann S.H., Adjei A.A., Hubbard J.M., Costello B.A.  Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort. Invest New Drugs. 42(1): 127-135, 2024. PMID38270822.

15.       Enke T., Keswani R., Triggs J., Gannavarapu B., Mittal C., Sinha J., Kwasny M.J., Komanduri S. Adherence to quality indicators and best practices in surveillance endoscopy of barrett’s esophagus: A video-based assessment. Endoscopy International Open. 12(01): E90-E96, 2024. WOS:001145872800006.

16.       Fazliyeva R., Makhov P., Uzzo R.G., Kolenko V.M. Targeting npc1 in renal cell carcinoma. Cancers (Basel). 16(3)2024. PMID38339268.PMC10854724.

17.       Gaines T., Simhan J.  Adult hypospadias outcomes for the pediatric urologist. Curr Urol Rep, 2024. PMID38319558.

18.       Gharzai L.A., Morris E., Suresh K., Nguyen-Tân P.F., Rosenthal D.I., Gillison M.L., Harari P.M., Garden A.S., Koyfman S., Caudell J.J., Jones C.U., Mitchell D.L., Krempl G., Ridge J.A., Gensheimer M.F., Bonner J.A., Filion E., Dunlap N.E., Stokes W.A., Le Q.T., Torres-Saavedra P., Mierzwa M., Schipper M.J. Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: An individual patient data meta-analysis. Lancet Oncol. 25(3): 366-375, 2024. PMID38423050.

19.       Harmange G., Hueros R.A.R., Schaff D.L., Emert B., Saint-Antoine M., Kim L.C., Niu Z.J., Nellore S., Fane M.E., Alicea G.M., Weeraratna A.T., Simon M.C., Singh A., Shaffer S.M., Disrupting cellular memory to overcome drug resistance. Nature Communications. 14(1)2023.  WOS:001142811000001.

20.       Heinrich M.C., Jones R.L., George S., Gelderblom H., Schöffski P., von Mehren M., Zalcberg J.R., Kang Y.K., Razak A.A., Trent J., Attia S., Le Cesne A., Siontis B.L., Goldstein D., Boye K., Sanchez C., Steeghs N., Rutkowski P., Druta M., Serrano C., Somaiah N., Chi P., Reichmann W., Sprott K., Achour H., Sherman M.L., Ruiz-Soto R., Blay J.Y.,Bauer S., Ripretinib versus sunitinib in gastrointestinal stromal tumor: Ctdna biomarker analysis of the phase 3 intrigue trial. Nat Med. 30(2): 498-506, 2024. PMID38182785.PMC10878977.

21.       Henderson T.O., Allen M.A., Mim R., Egleston B., Fleisher L., Elkin E., Oeffinger K., Krull K., Ofidis D., McLeod B., Griffin H., Wood E., Cacioppo C., Weinberg M., Brown S., Howe S., McDonald A., Vukadinovich C., Alston S., Rinehart D., Armstrong G.T., Bradbury A.R. The engage study: A 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative pcp model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors. BMC Health Serv Res. 24(1): 253, 2024. PMID38414045.PMC10900774.

22.       Hermida-Prado F., Xie Y.T., Sherman S., Nagy Z., Russo D., Akhshi T., Chu Z.T., Feit A., Campisi M., Chen M.Y., Nardone A., Guarducci C., Lim K., Font-Tello A., Lee I., García-Pedrero J., Cañadas I., Agudo J., Huang Y., Sella T., Jin Q.C., Tayob N., Mittendorf E.A., Tolaney S.M., Qiu X.T., Long H.Y., Symmans W.F., Lin J.R., Santagata S., Bedrosian I., Yardley D.A., Mayer I.A., Richardson E.T., Oliveira G., Wu C.J., Schuster E.F., Dowsett M., Welm A.L., Barbie D., Metzger O., Jeselsohn R. Endocrine therapy synergizes with smac mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer. Cancer Research. 83(19): 3284-3304, 2023. PMIDWOS:001083040500015.

23.       Howell K.J., Jain A. Endometrial cancer treatment: Long-term engagement strategies. International Journal of Radiation Oncology Biology Physics. 118(2): 321-321, 2024. WOS:001164953000001. Editorial.

24.       Isali I., Helstrom E.K., Uzzo N., Lakshmanan A., Nandwana D., Valentine H., Sindhani M., Abbosh P., Bukavina L.  Current trends and challenges of microbiome research in bladder cancer. Curr Oncol Rep, 2024. PMID38376627.

25.       Joshi K., Luisi B., Wunderlin G., Saleh S., Lilly A., Okusolubo T., Farabaugh P.J. An evolutionarily conserved phosphoserine-arginine salt bridge in the interface between ribosomal proteins us4 and us5 regulates translational accuracy in saccharomyces cerevisiae. Nucleic Acids Research, 2024. WOS:001160158300001.

26.       Keating M., Ferrada P., O’Halloran P.J., Perry W., Potter S., Reddy S.S., Wilder F.G., Reynolds I.S., Tips for early career academic surgeons. Am J Surg, 2024. PMID38302367.

27.       Kehm R.D., Knight J.A., Houghton L.C., McDonald J.A., Schwartz L.A., Goldberg M., Chung W.K., Frost C.J., Wei Y., Bradbury A.R., Keegan T.H.M., Daly M.B., Buys S.S., Andrulis I.L., John E.M., Terry M.B. Childhood physical activity and pubertal timing: Findings from the legacy girls study. Int J Epidemiol. 53(1)2024. PMID38205889.PMC10859159.

28.       Khushman M.M., Toboni M.D., Xiu J., Manne U., Farrell A., Lou E., Shields A.F., Philip P.A., Salem M.E., Abraham J., Spetzler D., Marshall J., Jayachandran P., Hall M.J., Lenz H.J., Sahin I.H., Seeber A., Powell M.A.  Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations. Clin Cancer Res, 2024. PMID38350001.

29.       Kuter B.J., Brien K., Anderson S., Bass S.B., Gutierrez L., Winters S., Eichenlaub B., Whitfield C., Faig W. Covid-19 vaccine perspectives and uptake among university students three years into the pandemic. Vaccine, 2024. PMID38365478.

30.       Lazim A., Mackrides N., Nasibli J., Pei J., Nejati R. ,Mansoor N. A t(14;18) negative nodal diffuse follicular lymphoma with 1p36/tnfrsf14 loh detected by cytogenomic microarray analysis. American Journal of Clinical Pathology. 160: S68-S68, 2023. WOS:001117683500001.

31.       Luck C.C., Bass S.B., Chertock Y., Kelly P.J.A., Singley K., Hoadley A., Hall M.J. Understanding perceptions of tumor genomic profile testing in Black/African American cancer patients in a qualitative study: The role of medical mistrust, provider communication, and family support. J Community Genet, 2024. PMID38366313.

32.       Mak K.S., Scannell Bryan M., Dignam J.J., Shipley W.U., Lin Y., Peters C.A., Gore E.M., Rosenthal S.A., Zeitzer K.L., D’Souza D.P., Horwitz E.M., Pisansky T.M., Maier J.M., Chafe S.M., Robin T.P., Roach M., 3rd, Tran P.T., Souhami L., Michalski J.M., Hartford A.C., Feng F.Y., Sandler H.M., Efstathiou J.A. Cardiovascular mortality and duration of androgen deprivation in locally advanced prostate cancer: Long-term update of nrg/rtog 9202. Eur Urol Focus, 2024. PMID38307806.

33.       Masuda M.Y., Pyon G.C., Luo H., LeSuer W.E., Putikova A., Dao A., Ortiz D.R., Schulze A.R., Fritz N., Kobayashi T., Iijima K., Klein-Szanto A.J., Shimonosono M., Flashner S., Morimoto M., Pai R.K., Rank M.A., Nakagawa H., Kita H., Wright B.L., Doyle A.D. Epithelial overexpression of il-33 induces eosinophilic esophagitis dependent on il-13. J Allergy Clin Immunol, 2024. PMID38310974.

34.       Morgan T.M., Boorjian S.A., Buyyounouski M.K., Chapin B.F., Chen D.Y.T., Cheng H.H., Chou R., Jacene H.A., Kamran S.C., Kim S.K., Kirkby E., Luckenbaugh A.N., Nathanson B.J., Nyame Y.A., Posadas E.M., Tran P.T., Chen R.C. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part i: Introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy. J Urol: 101097ju0000000000003892, 2024. PMID38421253.

35.       Morgan T.M., Boorjian S.A., Buyyounouski M.K., Chapin B.F., Chen D.Y.T., Cheng H.H., Chou R., Jacene H.A., Kamran S.C., Kim S.K., Kirkby E., Luckenbaugh A.N., Nathanson B.J., Nyame Y.A., Posadas E.M., Tran P.T., Chen R.C. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part iii: Salvage therapy after radiotherapy or focal therapy, pelvic nodal recurrence and oligometastasis, and future directions. J Urol: 101097ju0000000000003890, 2024. PMID38421252.

36.       Morgan T.M., Boorjian S.A., Buyyounouski M.K., Chapin B.F., Chen D.Y.T., Cheng H.H., Chou R., Jacene H.A., Kamran S.C., Kim S.K., Kirkby E., Luckenbaugh A.N., Nathanson B.J., Nyame Y.A., Posadas E.M., Tran P.T., Chen R.C. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part ii: Treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy. J Urol: 101097ju0000000000003891, 2024. PMID38421243.

37.       Moulton N., Abbasi M., Ahmad D., Burks A., Chenna P., Haas K., Loiselle A., Mekhaiel E., Pilli S., Sadoughi A., Lydon B., Patel T., Chen A.C. Inter- and intra-observer variability of radial-endobronchial ultrasound image interpretation for peripheral pulmonary lesions. J Thorac Dis. 16(1): 450-456, 2024. PMID38410559.PMC10894385.

38.       Mühlenberg T., Falkenhorst J., Schulz T., Fletcher B.S., Teuber A., Krzeciesa D., Klooster I., Lundberg M., Wilson L., Lategahn J., von Mehren M., Grunewald S., Tüns A.I., Wardelmann E., Sicklick J.K., Brahmi M., Serrano C., Schildhaus H.U., Sievers S., Treckmann J., Heinrich M.C., Raut C.P., Ou W.B., Marino-Enriquez A., George S., Rauh D., Fletcher J.A., Bauer S. Kit atp-binding pocket/activation loop mutations in gi stromal tumor: Emerging mechanisms of kinase inhibitor escape. J Clin Oncol: Jco2301197, 2024. PMID38408285.

39.       Muir A.B., Karakasheva T., Whelan K.A. Epithelial-fibroblast crosstalk in eosinophilic esophagitis. Cell Mol Gastroenterol Hepatol, 2024. PMID38316214.

40.       Nakata J.A., Arif A., Chai L.F., Su S. First report of a post-pneumonectomy nocardia empyema. J Surg Case Rep. 2024(1): rjae002, 2024. PMID38304314.PMC10832585.

41.       Naqash A.R., Floudas C.S., Aber E., Maoz A., Nassar A.H., Adib E., Choucair K., Xiu J., Baca Y., Ricciuti B., Alessi J.V., Awad M.M., Kim C., Judd J., Raez L.E., Lopes G., Nieva J.J., Borghaei H., Takebe N., Ma P.C., Halmos B., Kwiatkowski D.J., Liu S.V. ,Mamdani H.  Influence of tp53 comutation on the tumor immune microenvironment and clinical outcomes with immune checkpoint inhibitors in stk11-mutant non-small-cell lung cancer. JCO Precis Oncol. 8: e2300371, 2024. PMID38330261.PMC10860998.

42.       Neelapu S.S., Chavez J.C., Sehgal A.R., Epperla N., Ulrickson M., Bachy E., Munshi P.N., Casulo C., Maloney D.G., de Vos S., Reshef R., Leslie L.A., Oluwole O.O., Yakoub-Agha I., Khanal R., Rosenblatt J., Korn R., Peng W., Lui C., Wulff J., Shen R., Poddar S., Jung A.S., Miao H., Beygi S., Jacobson C.A. Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-hodgkin lymphoma (zuma-5). Blood. 143(6): 496-506, 2024. PMID37879047.

43.       Parham L.R., Williams P.A., Katada K., Nettleford S.K., Chatterji P., Acheampong K.K., Danan C.H., Ma X., Simon L.A., Naughton K.E., Mizuno R., Karakasheva T., McMillan E.A., Whelan K.A., Brady D.C., Shaffer S.M., Hamilton K.E. Igf2bp1/imp1 deletion enhances a facultative stem cell state via regulation of map1lc3b. Cell Mol Gastroenterol Hepatol. 17(3): 439-451, 2024. PMID38081361.PMC10835461.

44.       Parker C.S., Zhou L.L., Prabhu V.V., Lee S., Miner T.J., Ross E.A., El-Deiry W.S.  Onc201/tic10 plus tly012 anti-cancer effects via apoptosis inhibitor downregulation, stimulation of integrated stress response and death receptor dr5 in gastric adenocarcinoma. American Journal of Cancer Research. 13(12): 6290-6312, 2023. WOS:001143926000003.

45.       Poloyac S.M., Daugherty K.K., DeVilliers M.M., Farrell D.F., Malhotra A., Nolin T.D., Panyam J., Perumal O., Sheaffer E.A., Swaan P.W. Report of the 2023 aacp council of deans taskforce on pharmacy research and scholarship. Am J Pharm Educ. 88(2): 100641, 2024. PMID38185465.

46.       Preston K.J., Kawai T., Torimoto K., Kuroda R., Nakayama Y., Akiyama T., Kimura Y., Scalia R., Autieri M.V., Rizzo V., Hashimoto T., Osei-Owusu P., Eguchi S.  Mitochondrial fission inhibition protects against hypertension induced by angiotensin ii. Hypertens Res, 2024. PMID38383894.

47.       Reese J.B., Bauman J.R., Sorice K.A., Frederick N., Bober S.L., Hematology and oncology fellow education about sexual and reproductive health: A survey of program directors in the united states. JCO Oncol Pract: Op2300499, 2024. PMID38320223.

48.       Saaoud F., Lu Y., Xu K., Shao Y., Praticò D., Vazquez-Padron R.I., Wang H., Yang X., Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers – targeting perk as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer. Pharmacol Ther. 255: 108604, 2024. PMID38360205.

49.       Sasaki M., Hara T., Wang J.X., Zhou Y., Kennedy K.V., Umeweni N.N., Alston M.A., Spergel Z.C., Ishikawa S., Teranishi R., Nakagawa R., McMillan E.A., Whelan K.A., Karakasheva T.A., Hamilton K.E., Ruffner M.A., Muir A.B. Lysyl oxidase regulates epithelial differentiation and barrier integrity in eosinophilic esophagitis. Cell Mol Gastroenterol Hepatol, 2024. PMID38340809.

50.       Sherry D.R., Patell R., Han H.J., Dodge L.E., Braun I.M., Buss M.K., Palliative medicine fellows’ discussions, perceptions, and training regarding medical cannabis. J Pain Symptom Manage, 2024. PMID38417464.

51.       Simons M., Sharaiha R.Z., Updates in metabolic bariatric endoscopy. Dig Endosc. 36(2): 107-115, 2024. PMID37405807.

52.       Sterling J., Simhan J., Flynn B.J., Rusilko P., França W.A., Ramirez E.A., Angulo J.C., Martins F.E., Patel H.V., Higgins M., Swerdloff D., Nikolavsky D., Reply by authors. J Urol: 101097ju0000000000003888, 2024. PMID38382012.

53.       Strother M., Barlotta R., Uzzo R., Bloom E., Jazayeri S.B., Bigalli A.C., Schober J., Lee J., Bernstein A., Ginsburg K., Handorf E., Chen D.Y., Correa A., Greenberg R., Smaldone M., Viterbo R., Kutikov A. Symptomatic and functional recovery after transurethral resection of bladder tumor: Data from ecological momentary symptom assessment. Urol Oncol, 2024. PMID38369443.

54.       Sun J., Karasaki K.M., Farma J.M. The use of gene expression profiling and biomarkers in melanoma diagnosis and predicting recurrence: Implications for surveillance and treatment. Cancers (Basel). 16(3)2024. PMID38339333.PMC10854922.

55.       Sun Y., Young M.C., Woodward C.H., Danon J.N., Truong H., Gupta S., Winters T.J., Font-Burgada J., Burslem G.M., Sgourakis N.G. Universal open mhc-i molecules for rapid peptide loading and enhanced complex stability across hla allotypes. Proceedings of the National Academy of Sciences of the United States of America. 120(25)2023. WOS:001041283500001.

56.       Topchu I., Bychkov I., Gursel D., Makhov P., Boumber Y. Nsd1 supports cell growth and regulates autophagy in hpv-negative head and neck squamous cell carcinoma. Cell Death Discov. 10(1): 75, 2024. PMID38346948.PMC10861597.

57.       Torres-Ayuso P., Katerji M., Mehlich D., Lookingbill S.A., Sabbasani V.R., Liou H., Casillas A.L., Chauhan S.S., Serwa R., Rubin M.R., Marusiak A.A., Swenson R.E., Warfel N.A., Brognard J. Pim1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Cell Chem Biol. 31(2): 326-337.e11, 2024. PMID38016478.

58.       Trujillo M.N., Jennings E.Q., Hoffman E.A., Zhang H., Phoebe A.M., Mastin G.E., Kitamura N., Reisz J.A., Megill E., Kantner D., Marcinkiewicz M.M., Twardy S.M., Lebario F., Chapman E., McCullough R.L., D’Alessandro A., Snyder N.W., Cusanovich D.A., Galligan J.J. Lactoylglutathione promotes inflammatory signaling in macrophages through histone lactoylation. Mol Metab. 81: 101888, 2024. PMID38307385.PMC10869261.

59.       Uboveja A., Huang Z., Buj R., Amalric A., Wang H., Tangudu N.K., Cole A.R., Megill E., Kantner D., Chatoff A., Ahmad H., Marcinkiewicz M.M., Disharoon J.A., Graff S., Dahl E.S., Hempel N., Stallaert W., Sidoli S., Bitler B.G., Long D.T., Snyder N.W., Aird K.M. Αkg-mediated carnitine synthesis promotes homologous recombination via histone acetylation. bioRxiv, 2024. PMID38370789.PMC10871207 (Pre-Print).

60.       Wang Y., He S., Calendo G., Bui T., Tian Y.Y., Lee C.Y., Zhou Y., Zhao X., Abraham C., Mo W.B., Chen M.M., Sanders-Braggs R., Madzo J., Issa J.P., Hexner E.O., Wiest D.L., Reshef R., Xue H.H., Zhang Y. Tissue-infiltrating alloreactive t cells require id3 to deflect pd-1-mediated immune suppression during gvhd. Blood. 143(2): 166-177, 2024. WOS:001155837900001.

61.       Wei S., Krause H.B., Geynisman D.M., Elliott A., Kutikov A., Uzzo R.G., Pei J., Barata P., Carneiro B., Heath E., Ryan C., Farrell A., Nabhan C., Ali-Fehmi R., Naqash A.R., Argani P.,McKay R.R., Molecular characterization of tfe3-rearranged renal cell carcinoma: A comparative study with papillary and clear cell renal cell carcinomas. Mod Pathol. 37(2): 100404, 2024. PMID38104891.

62.       Yang Y., Liu L., Tian Y., Gu M., Wang Y., Ashrafizadeh M., Reza Aref A., Cañadas I., Klionsky D.J., Goel A., Reiter R.J., Wang Y., Tambuwala M.,Zou J., Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics. Cancer Lett. 587: 216659, 2024. PMID38367897.

63.       Yong V., Rostmeyer K., Erkmen C.P. Reply from authors: Reading between the lines: Guidance for applicants and authors of letters of recommendation. J Thorac Cardiovasc Surg. 167(3): e61-e62, 2024. PMID37768259.

64.       Zabransky D.J., Chhabra Y., Fane M.E., Kartalia E., Leatherman J.M., Hüser L., Zimmerman J.W., Delitto D., Han S., Armstrong T.D., Charmsaz S., Guinn S., Pramod S., Thompson E.D., Hughes S.J., O’Connell J., Egan J.M., Jaffee E.M., Weeraratna A.T. Fibroblasts in the aged pancreas drive pancreatic cancer progression. Cancer Res, 2024. PMID38330147.

Learn More

• Talbot Library Staff Publications Guide
• Staff Publications Database

Getting Full Text Articles

There are four easy ways to get access to full text articles.  This post will briefly go over each option so you can decide the best way to get your articles. 

But first some general information to keep in mind.  Going directly to the publisher’s website, googling an article, or using a site like Google Scholar or Research Gate won’t get you access to the library’s paid subscriptions, you’ll always need to authenticate to get access to subscription journals.  The best way to get an article is through the library’s website.

Use PubMed

PubMed is a great resource for finding full text articles.  Using the Talbot Research Library’s special PubMed link will get you access to all the subscriptions held by the library while are searching in PubMed, you’ll easily see which articles are available and which one’s you’ll need to request an interlibrary loan for. 

Here are some basic instructions for using the Talbot Library’s PubMed Link to get articles:

• Go to the Talbot Research Library’s PubMed Link and copy the article title into the search bar.
• Once you find the article you want click on the title.
• On the right-hand side of the page, you will see a row of buttons.  Click on the teal-colored button that says Online Full Text (this is the Talbot button holdings button) you should see a login in screen.
• Use your Fox Chase login (the same one you use to access the Hub) this will take you to the publisher’s website where you can download the article as a pdf.
• If the library doesn’t hold the journal you need you’ll see a page to request an interlibrary loan.  Fill out the form and submit it to the library.  We will fill find the request and send the article to you via email.
• This subject Guide about finding full text has instructions outlining how to use PubMed to get full text articles, scroll to the bottom of the page.

Use the Talbot Library’s A to Z Journal Page

If you want to access an article directly from a publisher’s website, or you want to browse a journal title the best way to get full text access is to access the library’s journal A to Z list.  This list will show you the active subscriptions from the library as well as the range of dates held for each title.  The list will give you a link to the publisher’s website where you can authenticate and get access to the journal holdings directly.

Here are some instructions on accessing the library’s journal holdings list:

• Go the Talbot Library website and click on the Find Journals link on the main page.
• Search for the journal title you want to access in the search box.
• Find the title you want and click on the link to the publisher’s website.
• Use your Fox Chase login (the same one you use to access the Hub) you’ll now be able download the article as a pdf.

If the library doesn’t offer access to the title you need please use the article/book request form on library’s website to request a copy.

Find articles in a database

If you are searching in a database such as Web of Science or Cinahl and you find an article you want, you can usually access the full text article in the database.  Look for buttons or links that say Find Full Text, or Access full Text.  Once you select full text you should be asked to authenticate and if the library subscribes to the title you will get access to the article.  Each database is different but all of them have some type of full text access.  If you don’t see a link or you can’t access the article use the article/book request form on library’s website to request a copy.  A full list of library databases can be found here.

Find Open Access articles

More and more articles are being published as open access.  Sites like PubMed Central and browser extensions like UnpayWall can help you find open access articles available for free use.  You may also various versions of open access articles on preprint archives such as bioRxiv.

Another option is to search for open access journals on sites such as the Directory of Open Access Journals.

Finally, if you use either Browzine or Read by QxMD (both available free from the Talbot Research Library) you can get access to both paid subscriptions and open access articles in these apps.  Learn more about using them in our Current Awareness Subject Guide.

Finding the articles you need should be easy.  Remember if you need any assistance with articles or searches you can always reach out to the Talbot Librarians.  We are happy to help with all your research needs.  Call, email, or stop by Reimann 224 for assistance.

Learn More

• Talbot Library Homepage
• Talbot Library’s PubMed Link
• Talbot Library Article Request Form
• Find Full Text Subject Guide
• PubMed Central
• Talbot Library’s UnPaywall Guide
• Talbot Library Preprint Guide
• Talbot Library’s Browzine Guide
• Talbot Library’s Read by QxMD Guide

Staff Publications Received in January, 2024

1.        Andreeva T.V., Maluchenko N.V., Efremenko A.V., Lyubitelev A.V., Korovina A.N., Afonin D.A., Kirpichnikov M.P., Studitsky V.M., Feofanov A.V., Epigallocatechin gallate affects the structure of chromatosomes, nucleosomes and their complexes with parp1. Int J Mol Sci. 24(18)2023. PMID37762491. PMC10532227.

2.        Araya S., Hackley M., Amadio G.M., Deng M., Moss C., Reinhardt E., Walchak A., Tecce M.G., Patel S.A. Survey of surgeon-reported postoperative protocols for deep inferior epigastric perforator flap in breast reconstruction. Plast Reconstr Surg Glob Open. 11(11): e5402, 2023. PMID38025610. PMC10653572.

3.        Bai Y., Zhang X., Li Y., Qi F., Liu C., Ai X., Tang M., Szeto C., Gao E., Hua X., Xie M., Wang X., Tian Y., Chen Y., Huang G., Zhang J., Xiao W., Zhang L., Liu X., Yang Q., Houser S.R., Chen X., Protein kinase a is a master regulator of physiological and pathological cardiac hypertrophy. Circ Res, 2024. PMID38275112.

4.        Balderson B., Fane M., Harvey T.J., Piper M., Smith A., Bodén M. Systematic analysis of the transcriptional landscape of melanoma reveals drug-target expression plasticity. Brief Funct Genomics, 2024. PMID38183207.

5.        Barham D.W., Gross M.S., Lentz A.C., Simhan J., Yafi F.A.  AUA-recommended antibiotic prophylaxis for primary penile implantation results in a higher, not lower, risk for postoperative infection: A multicenter analysis. Reply. Journal of Urology. 209(5): 850-851, 2023. WOS:001144475200016.

6.        Barta J.A., Erkmen C.P., Shusted C.S., Myers R.E., Saia C., Cohen S., Wainwright J., Zeigler-Johnson C., Dako F., Wender R., Kane G.C., Vachani A., Rendle K.A., The Philadelphia lung cancer learning community: A multi-health-system, citywide approach to lung cancer screening. JNCI Cancer Spectr. 7(5)2023. PMID37713466. PMC10588937.

7.        Begum T.F., Patil V.S., Zhu L., Yeh M.C., González E., Fraser M.A., Lu W., Zhu S., Rubio-Torio N., Ma G.X., Tan Y.  Assessing physicians’ recommendations for hepatitis b virus (hbv) and hepatitis c virus (hcv) testing among minority populations in greater Philadelphia and New York City. J Community Health, 2024. PMID38286964.

8.        Borghaei H., O’Byrne K.J., Paz-Ares L., Ciuleanu T.E., Yu X., Pluzanski A., Nagrial A., Havel L., Kowalyszyn R.D., Valette C.A., Brahmer J.R., Reck M., Ramalingam S.S., Zhang L., Ntambwe I., Rabindran S.K., Nathan F.E., Balli D.,Wu Y.L., Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: Results of the phase III checkmate 227 part 2 trial. ESMO Open. 8(6): 102065, 2023. PMID37988950. PMC10774956.

9.        Burdo T.H., Chen C., Kaminski R., Sariyer I.K., Mancuso P., Donadoni M., Smith M.D., Sariyer R., Caocci M., Liao S., Liu H., Huo W., Zhao H., Misamore J., Lewis M.G., Simonyan V., Thompson E.E., Xu E.Y., Cradick T.J., Gordon J., Khalili K., Correction: Preclinical safety and biodistribution of crispr targeting siv in non-human primates. Gene Ther, 2024. PMID38212405.

10.      Cannon A.C., Budagyan K., Uribe-Alvarez C., Kurimchak A.M., Araiza-Olivera D., Cai K.Q., Peri S., Zhou Y., Duncan J.S., Chernoff J. Unique vulnerability of rac1-mutant melanoma to combined inhibition of cdk9 and immune checkpoints. Oncogene, 2024. PMID38243078.

11.      Chang C., Barham D.W., Dalimov Z., Swerdloff D., Sadeghi-Nejad H., Andrianne R., Sempels M., Hsieh T.C., Hatzichristodoulou G., Hammad M., Miller J., Osmonov D., Lentz A., Perito P., Suarez-Sarmiento A., Hotaling J., Gross K., Jones J.M., van Renterghem K., Park S.H., Nicholas Warner J., Ziegelmann M., Modgil V., Jones A., Pearce I., Gross M.S., Yafi F.A., Simhan J. Single dilation in primary inflatable penile prosthesis placement is associated with fewer corporal complications than sequential dilation. Urology. 181: 150-154, 2023. PMID37574145.

12.      Chen N., McGrath C.B., Ericsson C.I., Vaselkiv J.B., Rencsok E.M., Stopsack K.H., Guard H.E., Autio K.A., Rathkopf D.E., Enting D., Bitting R.L., Mateo J., Githiaka C.W., Chi K.N., Cheng H.H., Davis I.D., Anderson S.G., Badal S.A.M., Bjartell A., Russnes K.M., Heath E.I., Pomerantz M.M., Henegan J.C., Hyslop T., Esteban E., Omlin A., McDermott R., Fay A.P., Popoola A.A., Ragin C., Nowak J., Gerke T., Kantoff P.W., George D.J., Penney K.L.,Mucci L.A., Marital status, living arrangement, and survival among individuals with advanced prostate cancer in the international registry for men with advanced prostate cancer. Cancer Epidemiol Biomarkers Prev, 2024. PMID38189661.

13.      Deni W.H., Gao T., Wu J., Protocol for reconstituting peptides/peptidomimetics from dmso to aqueous buffers for circular dichroism analyses. STAR Protoc. 5(1): 102850, 2024. PMID38285735.

14.      Dotan E., Lynch S.M., Ryan J.C., Mitchell E.P.  Disparities in care of older adults of color with cancer: A narrative review. Cancer Med, 2024. PMID38234214.

15.      Emiloju O.E., Yin J., Koubek E., Reid J.M., Borad M.J., Lou Y., Seetharam M., Edelman M.J., Sausville E.A., Jiang Y., Kaseb A.O., Posey J.A., Davis S.L., Gores G.J., Roberts L.R., Takebe N., Schwartz G.K., Hendrickson A.E.W., Kaufmann S.H., Adjei A.A., Hubbard J.M., Costello B.A., Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort. Invest New Drugs, 2024. PMID38270822.

16.      Enke T., Keswani R., Triggs J., Gannavarapu B., Mittal C., Sinha J., Kwasny M.J., Komanduri S.  Adherence to quality indicators and best practices in surveillance endoscopy of Barrett’s esophagus: A video-based assessment. Endosc Int Open. 12(1): E90-e96, 2024. PMID38250164.PMC10798847.

17.      Gerber D.E., Wang Y., Ramalingam S.S., Bhalla S., Sun Z., Borghaei H., Brahmer J.R., Schiller J.H. Incidence, correlates, and prognostic significance of mixed response in advanced non-small cell lung cancer. Oncologist, 2024. PMID38207008.

18.      Hanna G.J., Chang S.S., Siddiqui F., Bain P.A., Takiar V., Ward M.C., Shukla M.E., Hu K.S., Robbins J., Witek M.E., Bakst R., Chandra R.A., Galloway T. ,Margalit D.N.  Imaging and biomarker surveillance for head and neck squamous cell carcinoma: A systematic review and appropriate use criteria document. Int J Radiat Oncol Biol Phys, 2023. PMID38168554.

19.      Harmange G., Hueros R.A.R., Schaff D.L., Emert B., Saint-Antoine M., Kim L.C., Niu Z., Nellore S., Fane M.E., Alicea G.M., Weeraratna A.T., Simon M.C., Singh A., Shaffer S.M., Disrupting cellular memory to overcome drug resistance. Nat Commun. 14(1): 7130, 2023. PMID37932277. PMC10628298.

20.      Heinrich M.C., Jones R.L., George S., Gelderblom H., Schöffski P., von Mehren M., Zalcberg J.R., Kang Y.K., Razak A.A., Trent J., Attia S., Le Cesne A., Siontis B.L., Goldstein D., Boye K., Sanchez C., Steeghs N., Rutkowski P., Druta M., Serrano C., Somaiah N., Chi P., Reichmann W., Sprott K., Achour H., Sherman M.L., Ruiz-Soto R., Blay J.Y., Bauer S., Ripretinib versus sunitinib in gastrointestinal stromal tumor: Ctdna biomarker analysis of the phase 3 intrigue trial. Nat Med, 2024. PMID38182785.

21.      Howell K.J., Jain A.  Endometrial cancer treatment: Long-term engagement strategies. Int J Radiat Oncol Biol Phys. 118(2): 321, 2024. PMID38220253.

22.      Iyer S.P., Johnston P.B., Barta S.K., Pralatrexate injection combined with chop for treatment of ptcl: Results from the fol-chop dose-finding phase 1 trial. Blood Adv. 8(2): 353-364, 2024. PMID38029357. PMC10788850.

23.      Kashyap D., Tanwar M., Rani C., Bagde P.H., Singh S., Varshney N., Saini V., Mishra A., Kumar R., Jha H.C.  Spectroscopic assessment of biomolecular changes in <i>helicobacter pylori</i> and epstein-barr virus co-infected gastric epithelial cells. Journal of Raman Spectroscopy, 2024. WOS:001146330500001.

24.      Kasper G., Momen M., Sorice K.A., Mayhand K.N., Handorf E.A., Gonzalez E.T., Devlin A., Brownstein K., Esnaola N., Fisher S.G.,Lynch S.M., Effect of neighborhood and individual-level socioeconomic factors on breast cancer screening adherence in a multi-ethnic study. BMC Public Health. 24(1): 63, 2024. PMID38166942. PMC10763410.

25.      Kehm R.D., Knight J.A., Houghton L.C., McDonald J.A., Schwartz L.A., Goldberg M., Chung W.K., Frost C.J., Wei Y., Bradbury A.R., Keegan T.H.M., Daly M.B., Buys S.S., Andrulis I.L., John E.M., Terry M.B., Childhood physical activity and pubertal timing: Findings from the legacy girls study. Int J Epidemiol, 2024. PMID38205889.

26.      Kumar S.K., Callander N.S., Adekola K., Anderson L.D., Jr., Baljevic M., Baz R., Campagnaro E., Castillo J.J., Costello C., D’Angelo C., Derman B., Devarakonda S., Elsedawy N., Garfall A., Godby K., Hillengass J., Holmberg L., Htut M., Huff C.A., Hultcrantz M., Kang Y., Larson S., Lee H., Liedtke M., Martin T., Omel J., Robinson T., Rosenberg A., Sborov D., Schroeder M.A., Sherbenou D., Suvannasankha A., Valent J., Varshavsky-Yanovsky A.N., Snedeker J., Kumar R., Waldenström macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 22(1d): e240001, 2024. PMID38244272.

27.      Li Y., He X., Wheldon C., Wu Y., Prosperi M., Shenkman E.A., Jaffee M.S., Guo J., Wang F., Guo Y., Bian J., A computable phenotype for the identification of sexual and gender minorities in electronic health records. AMIA Annu Symp Proc. 2023: 1057-1066, 2023. PMID38222414. PMC10785915.

28.      Liao R.S., Ruan H.T., Jang A., Huynh M., Nadal Rios R., Hoffman-Censits J.H., Wei S., Mian O.Y., Barata P.C , Emerging insights in small-cell carcinoma of the genitourinary tract: From diagnosis to novel therapeutic horizons. Am Soc Clin Oncol Educ Book. 44: e430336, 2024. PMID38176691.

29.      Lukez A., Handorf E., Mendenhall N.P., Henderson R.H., Stish B.J., Davis B.J., Hallman M., Horwitz E.M., Vapiwala N., Wong J.K., A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer. Prostate. 84(4): 395-402, 2024. PMID38108113.

30.      Magee D.E., Bukavina L. ,Correa A., Reply: Taking a stand: No conferences in anti-abortion states. J Urol. 211(2): 324-325, 2024. PMID38193407.

31.      Murayama T., Nakayama J., Jiang X., Miyata K., Morris A.D., Cai K.Q., Prasad R.M., Ma X., Efimov A., Belani N., Gerstein E.R., Tan Y., Zhou Y., Kim W., Maruyama R., Campbell K.S., Chen L., Yang Y., Balachandran S., Canadas I., Targeting dhx9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer. Cancer Discov, 2024. PMID38189443.

32.      Najafali D., Reiche E., Araya S., Camacho J.M., Liu F.C., Johnstone T., Patel S.A., Morrison S.D., Dorafshar A.H.,Fox P.M., Bard versus the 2022 American Society of Plastic Surgeons in-service examination: Performance on the examination in its intern year. Aesthetic Surgery Journal Open Forum. 6: ojad066, 2024. WOS:001138526600001. PMC10776237.

33.      Parker C.S., Zhou L., Prabhu V.V., Lee S., Miner T.J., Ross E.A., El-Deiry W.S., Onc201/tic10 plus tly012 anti-cancer effects via apoptosis inhibitor downregulation, stimulation of integrated stress response and death receptor dr5 in gastric adenocarcinoma. Am J Cancer Res. 13(12): 6290-6312, 2023. PMID38187068.PMC10767330.

34.      Purev E., Bahmed K.,Kosmider B., Alveolar organoids in lung disease modeling. Biomolecules. 14(1)2024. PMID38254715. PMC10813493.

35.      Rodriguez A.L., Cappelletti L., Kurian S.M., Passio C., Rux S., Transitional care navigation. Semin Oncol Nurs: 151580, 2024. PMID38290928.

36.      Sahin Y., Wang Y.L., Pei J., Mansoor N., Styler M., Testa J.R., Nejati R., Multiple genomic alterations, including a novel aff4::Irf1 fusion gene, in a treatment-refractory blastic plasmacytoid dendritic-cell neoplasm: A case report and literature review. Int J Mol Sci. 25(1)2023. PMID38203475. PMC10778852.

37.      Schmults C.D., Blitzblau R., Aasi S.Z., Alam M., Amini A., Bibee K., Bolotin D., Bordeaux J., Chen P.L., Contreras C.M., DiMaio D., Donigan J.M., Farma J.M., Ghosh K., Harms K., Ho A.L., Lukens J.N., Manber S., Mark L., Medina T., Nehal K.S., Nghiem P., Olino K., Park S., Patel T., Puzanov I., Rich J., Sekulic A., Shaha A.R., Srivastava D., Thomas V., Tomblinson C., Venkat P., Xu Y.G., Yu S., Yusuf M., McCullough B., Espinosa S.  NCCN guidelines® insights: Merkel cell carcinoma, version 1.2024. J Natl Compr Canc Netw. 22(1d): e240002, 2024. PMID38244274.

38.      Shah S.M., Demidova E.V., Ringenbach S., Faezov B., Andrake M., Gandhi A., Mur P., Viana-Errasti J., Xiu J., Swensen J., Valle L., Dunbrack R.L., Jr., Hall M.J., Arora S. Exploring co-occurring pole exonuclease and non-exonuclease domain mutations and their impact on tumor mutagenicity. Cancer Res Commun. 4(1): 213-25, 2024. PMID38207205.PMC10812383.

39.      Siminoff L.A., Alolod G.P., McGregor H., Hasz R.D., Mulvania P.A., Barker L.K., Gardiner H.M., Developing online communication training to request donation for vascularized composite allotransplantation (vca): Improving performance to match new us organ donation targets. BMC Med Educ. 24(1): 77, 2024. PMID38254115.PMC10802059.

40.      Sterling J., Simhan J., Flynn B.J., Rusilko P., Franca W.A., Ramirez E.A., Angulo J.C., Martins F.E., Patel H.V., Higgins M., Swerdloff D., Nikolavsky D., Multi-institutional outcomes of dorsal onlay buccal mucosal graft urethroplasty in patients with postprostatectomy, postradiation anastomotic stenosis. J Urol: 101097ju0000000000003848, 2024. PMID38275201.

41.      Tawfik Z.A., Farid M.E., Shahat K.M.E., Hussein A.A., Eldib A.A., Al Etreby M., A dosimetric study comparing cyberknife and linac-based stereotactic radiotherapy or radiosurgery treatments. Journal of Radiation Research and Applied Sciences. 17(1)2024. WOS:001135169000001.

42.      Toma M.M., Karami A., Nieborowska-Skorska M., Chirtala K.N., Pepek M., Hadzijusufovic E., Stoklosa T., Valent P., Skorski T. Clonal medicine targeting DNA damage response eradicates leukemia. Leukemia, 2024. PMID38228681.

43.      Ubba V., Joseph S., Awe O., Jones D., Dsilva M.K., Feng M., Wang J., Fu X., Akbar R.J., Bodnar B.H., Hu W., Wang H., Yang X., Yang L., Yang P., Taib B., Ahima R., Divall S.,Wu S., Reproductive profile of neuronal androgen receptor knockout female mice with a low dose of dht. Endocrinology. 165(3)2024. PMID38156784. PMC10794876.

44.      Whitehead R.A., Patel E.A., Liu J.C., Bhayani M.K.  Racial disparities in head and neck cancer: It’s not just about access. Otolaryngol Head Neck Surg, 2024. PMID38258967.

45.      Widstrom N.E., Andrianov G.V., Heier J.L., Heier C., Karanicolas J., Parker L.L.  Novel substrate prediction for the tam family of rtks using phosphoproteomics and structure-based modeling. ACS Chem Biol. 19(1): 117-128, 2024. PMID38159292.

46.      Williams A.D., Weiss A., Recent advances in the upfront surgical management of the axilla in patients with breast cancer. Clin Breast Cancer, 2023. PMID38220539.

47.      Yang J., Liu C., Deng W., Wu D., Weng C., Zhou Y., Wang K., Enhancing phenotype recognition in clinical notes using large language models: Phenobcbert and phenogpt. Patterns (N Y). 5(1): 100887, 2024. PMID38264716. PMC10801236.

48.      Zanti M., O’Mahony D.G., Parsons M.T., Li H.Y., Dennis J., Aittomäkkiki K., Andrulis I.L., Anton-Culver H., Aronson K.J., Augustinsson A., Becher H., Bojesen S.E., Bolla M.K., Brenner H., Brown M.A., Buys S.S., Canzian F., Caputo S.M., Castelao J.E., Chang-Claude J., Czene K., Daly M.B., De Nicolo A., Devilee P., Dörk T., Dunning A.M., Dwek M., Eccles D.M., Engel C., Evans D.G., Fasching P.A., Gago-Dominguez M., García-Closas M., García-Sáenz J.A., Gentry-Maharaj A., Geurts-Giele W.R.R., Giles G.G., Glendon G., Goldberg M.S., Garcia E.B.G., Güendert M., Guénel P., Hahnen E., Haiman C.A., Hall P., Hamann U., Harkness E.F., Hogervorst F.B.L., Hollestelle A., Hoppe R., Hopper J.L., Houdayer C., Houlston R.S., Howell A., Investigators A., Jakimovska M., Jakubowska A., Jernström H., John E.M., Kaaks R., Kitahara C.M., Koutros S., Kraft P., Kristensen V.N., Lacey J., Lambrechts D., Léoné M., Lindblom A., Lush M., Mannermaa A., Manoochehri M., Manoukian S., Margolin S., Martinez M.E., Menon U., Milne R.L., Monteiro A.N., Murphy R.A., Neuhausen S.L., Nevanlinna H., Newman W.G., Offit K., Park S.K., James P., Peterlongo P., Peto J., Plaseska-Karanfilska D., Punie K., Radice P., Rashid M.U., Rennert G., Romero A., Rosenberg E.H., Saloustros E., Sandler D.P., Schmidt M.K., Schmutzler R.K., Shu X.O., Simard J., Southey M.C., Stone J., Stoppa-Lyonnet D., Tamimi R.M., Tapper W.J., Taylor J.A., Teo S.H., Teras L.R., Terry M.B., Thomassen M., Troester M.A., Vachon C.M., Vega A., Vreeswijk M.P.G., Wang Q., Wappenschmidt B., Weinberg C.R., Wolk A., Zheng W., Feng B.J., Couch F.J., Spurdle A.B., Easton D.F., Goldgar D.E., Michailidou K.,Collaborators G.-H.S., A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to brca1 and brca2. Human Mutation. 2023: 1-17, 2023. WOS:001091490300001.

Learn More

• Talbot Library Staff Publications Guide
• Staff Publications Database

Staff Publications Received in December, 2023

1.         Abu-Rustum N.R., Yashar C.M., Arend R., Barber E., Bradley K., Brooks R., Campos S.M., Chino J., Chon H.S., Crispens M.A., Damast S., Fisher C.M., Frederick P., Gaffney D.K., Gaillard S., Giuntoli R., Glaser S., Holmes J., Howitt B.E., Lea J., Mantia-Smaldone G., Mariani A., Mutch D., Nagel C., Nekhlyudov L., Podoll M., Rodabaugh K., Salani R., Schorge J., Siedel J., Sisodia R., Soliman P., Ueda S., Urban R., Wyse E., McMillian N.R., Aggarwal S.,Espinosa S., NCCN Guidelines® Insights: Cervical cancer, version 1.2024. J Natl Compr Canc Netw. 21(12): 1224-1233, 2023. PMID38081139.

2.         Behrens S., Lillemoe H.A., Dineen S.P., Russell M.C., Visser B., Berman R.S., Farma J.M., Grubbs E.,Davis J.L., Perceptions of readiness for practice after complex general surgical oncology fellowship: A survey study. Ann Surg Oncol. 31(1): 31-41, 2024. PMID37936022.PMC10695882.

3.         Benton D.,Chernoff J., Rhoa drivers take alternate routes in gastric cancer. Sci Signal. 16(816): eadk9171, 2023. PMID38113334.

4.         Berman E., Shah N.P., Deninger M., Altman J.K., Amaya M., Begna K., Bhatia R., Chan O., Collins R., Curtin P., DeAngelo D.J., Drazer M., Maness L., Metheny L., Mohan S., Moore J., Oehler V., Pratz K., Pusic I., Rose M., Shomali W., Smith B.D., Styler M., Sweet K., Talpaz M., Tanaka T., Tantravahi S., Tsai S., Vaughn J., Welborn J., Yang D., Mauro M., Cortes J., Radich J.,Druker B., Cml and the who: Why? J Clin Oncol: Jco2301689, 2023. PMID38086008.

5.         Budde L.E., Olszewski A.J., Assouline S., Lossos I.S., Diefenbach C., Kamdar M., Ghosh N., Modi D., Sabry W., Naik S., Mehta A., Nakhoda S.K., Smith S.D., Dorritie K., Jia T., Pham S., Huw L.Y., Jing J., Wu H., Ead W.S., To I., Batlevi C.L., Wei M.C.,Chavez J.C., Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large b cell lymphoma: A phase 1b/2 trial. Nat Med, 2023. PMID38072960.

6.         Calbert M.L., Chandramouly G., Adams C.M., Saez-Ayala M., Kent T., Tyagi M., Ayyadevara V., Wang Y., Krais J.J., Gordon J., Atkins J., Toma M.M., Betzi S., Boghossian A.S., Rees M.G., Ronan M.M., Roth J.A., Goldman A.R., Gorman N., Mitra R., Childers W.E., Graña X., Skorski T., Johnson N., Hurtz C., Morelli X., Eischen C.M.,Pomerantz R.T., 4′-ethynyl-2′-deoxycytidine (edc) preferentially targets lymphoma and leukemia subtypes by inducing replicative stress. Mol Cancer Ther, 2023. PMID38064712.

7.         Chen Z., Cheng Z., Ding C., Cao T., Chen L., Wang H., Li J.,Huang X., Ros-activated trpm2 channel: Calcium homeostasis in cardiovascular/renal system and speculation in cardiorenal syndrome. Cardiovasc Drugs Ther, 2023. PMID38108918.

8.         Chen J., Bearz A., Kim D.W., Mamdani H., Bauman J., Chiari R., Ou S.I., Solomon B.J., Soo R.A., Felip E., Shaw A.T., Thurm H., Clancy J.S., Lee K., O’Gorman M., Tanski C.,Pithavala Y.K., Evaluation of the effect of lorlatinib on cyp2b6, cyp2c9, ugt, and p-glycoprotein substrates in patients with advanced non-small cell lung cancer. Clin Pharmacokinet, 2023. PMID38079095.

9.         Chiba M., Shimono J., Suto K., Ishio T., Endo T., Goto H., Hasegawa H., Maeda M., Teshima T., Yang Y.,Nakagawa M., Whole genome crispr screening identifies molecular mechanisms of pd-l1 expression in adult t-cell leukemia/lymphoma. Blood, 2023. PMID38142436.

10.       Chwistek M., Sherry D., Kinczewski L., Silveira M.J.,Davis M., Should buprenorphine be considered a first-line opioid for the treatment of moderate to severe cancer pain. Journal of Pain and Symptom Management. 66(5): e638-e643, 2023. WOS:001103584900001.

11.       Craig J.M., Gerhard G.S., Sharma S., Yankovskiy A., Miura S.,Kumar S., Methods for estimating personal disease risk and phylogenetic diversity of hematopoietic stem cells. Mol Biol Evol, 2023. PMID38124397.

12.       Dineen S.P., Behrens S., Grubbs E.G., Davis J.L.,Farma J.M., ASO author reflections: Surgical oncology fellowship training: Is training hitting the mark? Ann Surg Oncol, 2023. PMID38062295.

13.       Erkmen C.P., Chin K., Agarwal S., Adnan S., Cooke D.T.,Merrill W., The cost of being a woman in academic cardiothoracic surgery: Joint collaboration of the society of thoracic surgeons workforces on diversity, equity, and inclusion and cardiothoracic surgery practice models. Ann Thorac Surg. 117(1): 59-67, 2024. PMID37543350.

14.       Frosch Z.A.K., Jacobs L.M., O’Brien C.S., Brecher A.C., McKeown C.J., Lynch S.M., Geynisman D.M., Hall M.J., Edelman M.J., Bleicher R.J., Fang C.Y. “Cancer’s a demon”: A qualitative study of fear and multilevel factors contributing to cancer treatment delays. Support Care Cancer. 32(1): 13, 2023. PMID38060063.

15.       Hadadi A., Krause H.B., Elliott A., Brown J.T., Nazha B., Harik L.R., Carthon B.C., Miron B., Nabhan C., Barata P.C., Saleh M., Yang Y., McKay R.R.,Bilen M.A., The genomic landscape of urothelial carcinoma with high and low erbb2 expression. Cancers (Basel). 15(24)2023. PMID38136267.PMC10742086.

16.       Hasan A., Khamjan N., Lohani M.,Mir S.S., Targeted inhibition of hsp90 in combination with metformin modulates programmed cell death pathways in a549 lung cancer cells. Appl Biochem Biotechnol. 195(12): 7338-7378, 2023. PMID37000353.

17.       Hayek H., Rehbini O., Kosmider B., Brandt T., Chatila W., Marchetti N., Criner G.J., Bolla S., Kishore R., Bowler R.P., Bahmed K. The regulation of fasn by exosomal mir-143-5p and mir-342-5p in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol, 2023. PMID38117249.

18.       Hu B., Moiseev D., Schena I., Faezov B., Dunbrack R., Jonathan C. [Chernoff, J], Li J. Pak2 is necessary for myelination in the peripheral nervous system. Brain, 2023. PMID38079473.

19.       Kumar S.K., Callander N.S., Adekola K., Anderson L.D., Baljevic M., Baz R., Campagnaro E., Castillo J.J., Costello C., D’Angelo C., Devarakonda S., Elsedawy N., Garfall A., Godby K., Hillengass J., Holmberg L., Htut M., Huff C.A., Hultcrantz M., Kang Y., Larson S., Lee H.C., Liedtke M., Martin T., Omel J., Robinson T., Rosenberg A., Sborov D., Schroeder M.A., Sherbenou D., Suvannasankha A., Valent J., Varshavsky-Yanovsky A.N., Kumar R.,Snedeker J., Multiple myeloma, version 2.2024, NCCN Clinical Practice Guidelines in oncology. J Natl Compr Canc Netw. 21(12): 1281-1301, 2023. PMID38081133.

20.       Loghavi S., Kanagal-Shamanna R., Khoury J.D., Medeiros L.J., Naresh K.N., Nejati R.,Patnaik M.M., Fifth edition of the world health classification of tumors of the hematopoietic and lymphoid tissue: Myeloid neoplasms. Mod Pathol. 37(2): 100397, 2023. PMID38043791.

21.       Lukez A., Handorf E., Mendenhall N.P., Henderson R.H., Stish B.J., Davis B.J., Hallman M., Horwitz E.M., Vapiwala N.,Wong J.K., A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer. Prostate, 2023. PMID38108113.

22.       Meric-Bernstam F., Rothe M., Mangat P.K., Garrett-Mayer E., Gutierrez R., Ahn E.R., Cannon T.L., Powell S., Krauss J.C., Reynolds C.M., von Mehren M., Behl D., Calfa C.J., Duvivier H.L., Kaplan H.G., Livingston M.B., Sharma M.R., Urba W.J., Grantham G.N., Hinshaw D.C., Gregory A., Halabi S.,Schilsky R.L., Cobimetinib plus vemurafenib in patients with solid tumors with braf mutations: Results from the targeted agent and profiling utilization registry study. JCO Precis Oncol. 7: e2300385, 2023. PMID38096472.PMC10735080.

23.       O’Brien J.,Bodor J.N., Perioperative immunotherapy in non-small cell lung cancer. Curr Treat Options Oncol, 2023. PMID38091187.

24.       Omil-Lima D.,Kutikov A., Editorial comment. Urol Pract. 11(1): 47-48, 2024. PMID38051207.

25.       Parham L.R., Williams P.A., Katada K., Nettleford S.K., Chatterji P., Acheampong K.K., Danan C.H., Ma X., Simon L.A., Naughton K.E., Karakasheva T., McMillan E.A., Whelan K.A., Brady D.C., Shaffer S.M.,Hamilton K.E., Igf2bp1/imp1 deletion enhances a facultative stem cell state via regulation of map1lc3b. Cell Mol Gastroenterol Hepatol, 2023. PMID38081361.

26.       Plimack E.R., Powles T., Stus V., Gafanov R., Nosov D., Waddell T., Alekseev B., Pouliot F., Melichar B., Soulières D., Borchiellini D., McDermott R.S., Vynnychenko I., Chang Y.H., Tamada S., Atkins M.B., Li C., Perini R., Molife L.R., Bedke J.,Rini B.I., Corrigendum to “pembrolizumab plus axitinib versus sunitinib as first-line treatment of advanced renal cell carcinoma: 43-month follow-up of the phase 3 keynote-426 study” [eur urol 84(5) (2023) 449-454]. Eur Urol, 2023. PMID38071169.

27.       Price A.D., Foote D.C., Woeste M.R., Winer L.K., Montgomery K.B., Al Yafi M., Nahmias J.T., Postlewait L.M., Sutton J.M., Quillin R.C., Cortez A.R., Consortium U.R., Defining the disparity: A multi-institutional analysis of factors associated with decreased resident operative experience. Journal of Surgical Research. 293: 647-655, 2024. WOS:001103579100001.

28.       Raddi R.M.,Voelz V.A., Markov state model of solvent features reveals water dynamics in protein-peptide binding. J Phys Chem B. 127(50): 10682-10690, 2023. PMID38078851.

29.       Rencsok E.M., Slopen N., McManus H.D., Autio K.A., Morgans A.K., McSwain L., Barata P., Cheng H.H., Dreicer R., Gerke T., Green R., Heath E.I., Howard L.E., McKay R.R., Nowak J., Pileggi S., Pomerantz M.M., Rathkopf D.E., Tagawa S.T., Whang Y.E., Ragin C., Odedina F.T., Kantoff P.W., Vinson J., Villanti P., Haneuse S., Mucci L.A.,George D.J., Pain and its association with survival for Black and White individuals with advanced prostate cancer in the US. Cancer Res Commun, 2023. PMID38108490.

30.       Rohatgi N., Rothe M., Mangat P.K., Garrett-Mayer E., Meric-Bernstam F., Pisick E., Alese O.B., Reynolds C.M., Thota R., Vaccaro G.M., von Mehren M., Arend R.C., Chiu V.K., Duvivier H.L., Gold P.J., Hack K., Marr A.S., Winer A., Grantham G.N., Hinshaw D.C., Gregory A., Halabi S.,Schilsky R.L., Nivolumab plus ipilimumab in patients with solid tumors with atm mutations: Results from the targeted agent and profiling utilization registry (tapur) study. JCO Precis Oncol. 7: e2300279, 2023. PMID38039429.

31.       Sommer S.B., Barroso J.V., Bass S.B., Congema M.R., Schoemann A.M.,Caiola C.E., Peer advice for women living with hiv in the southern USA. Cult Health Sex: 1-16, 2023. PMID38047389.

32.       Thomas P.G., Shubina M.,Balachandran S., Zbp1/dai-dependent cell death pathways in influenza a virus immunity and pathogenesis. Curr Top Microbiol Immunol. 442: 41-63, 2023. PMID31970498.

33.       Vose J.M., Fu K., Wang L., Mansoor A., Stewart D., Cheng H., Smith L., Yuan J., Qureishi H.N., Link B.K., Cessna M.H., Barr P.M., Kahl B.S., McKinney M.S., Khan N., Advani R.H., Martin P., Goy A.H., Phillips T.J., Mehta A., Kamdar M., Crump M., Pro B., Flowers C.R., Jacobson C.A., Smith S.M., Stephens D.M., Bachanova V., Jin Z., Wu S., Hernandez-Ilizaliturri F., Torka P., Anampa-Guzmán A., Kashef F., Li X., Sharma S., Greiner T.C., Armitage J.O., Lunning M., Weisenburger D.D., Bociek R.G., Iqbal J., Yu G.,Bi C., Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: A report from the North American mantle cell lymphoma consortium. J Hematol Oncol. 16(1): 122, 2023. PMID38104096.PMC10725579.

34.       Wang R., Uzzo N., Chelluri R., Mackrides N., Ehya H., Pei J., Baldwin D.A., Wasik M.A., Wei S.,Uzzo R., Genomic evolution of oligometastatic clear cell renal cell carcinoma presenting two decades following radical nephrectomy. Urology, 2023. PMID38128834.

35.       Wei S., Krause H.B., Geynisman D.M., Elliott A., Kutikov A., Uzzo R.G., Pei J., Barata P., Carneiro B., Heath E., Ryan C., Farrell A., Nabhan C., Ali-Fehmi R., Naqash A.R., Argani P.,McKay R.R., Molecular characterization of tfe3-rearranged renal cell carcinoma, a comparative study with papillary and clear cell renal cell carcinomas. Mod Pathol: 100404, 2023. PMID38104891.

36.       Zhang Z., Zhang Y., Liu C., Shao J., Chen Y., Zhu Y., Zhang L., Qin B., Kong Z., Wang X., Wang Y., Huang D., Liu L., Zhou Y., Tao R., Yang Z., Liu M.,Zhao W., A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer. Cancer Innov. 2(3): 172-180, 2023. PMID38089401.PMC10686160.

Learn More

• Talbot Library Staff Publications Guide
• Staff Publications Database

Endnote Manuscript Matcher

Endnote Manuscript Matcher is a free tool found in the Endnote products that will help you match your completed article to a journal.  It can aid you in discovering which journal would be a good fit for your article.  You will need to use your Endnote Online login to access the finder.

Endnote Manuscript Matcher can be accessed three ways.  In the Endnote Desktop under Groups – Manuscript Matcher, in Endnote Online under Match and finally in Microsoft Word on the Endnote tab.  Manuscript matcher uses your Endnote references to find journals that fit your article topic best.

 

A form will pop up asking you to fill in your manuscript details.  After you enter the title and abstract and select the references you want to add press find journals and Endnote will search Web of Science and the Journal Citation Report databases to find journals that may match your article subject areas.

You’ll get a set of search results ranking the journals that best fit your topic.  You can see the specifics of each journal along with the journal impact factor and other important decision-making information.  It will even supply a link to the journal website to help you with submitting your article.

Using Endnote Manuscript Matcher won’t guarantee that your article will be published by the selected journals, it can make deciding where to submit your articles easier. 

Learn more about this feature from Endnote and much more on the Talbot Research Library’s Endnote Guide.  It’s a great place to get started using Endnote.

If you have any questions about Endnote or would like to discuss your research needs, please reach out to the library for assistance.  Call, email, or drop by the library to discuss your research, the librarians are happy to help.

Learn More

• Endnote Manuscript Matcher from Clarivate
• Introducing Manuscript Matcher
• Talbot Research Library’s Endnote Guide
• Talbot Research Library’s Manuscript Matcher Guide
• Endnote Manuscript Matcher Video

Staff Publications Received in November, 2023

1.         Achimba F., Faezov B., Cohen B., Dunbrack R., Holford M. Targeting dysregulated ion channels in liver tumors with venom peptides. Mol Cancer Ther, 2023. PMID38015557.

2.         Akumuo R.C., Villano A.M., Reddy S.P., Devarajan K., Barrak D., Reddy S.S., Type of neoadjuvant treatment strategy is associated with differential pathologic responses in pancreatic ductal adenocarcinoma. Am J Surg, 2023. PMID37977978.

3.         Araya S., Hackley M., Amadio G.M., Deng M., Moss C., Reinhardt E., Walchak A., Tecce M.G., Patel S.A.  Survey of surgeon-reported postoperative protocols for deep inferior epigastric perforator flap in breast reconstruction. Plast Reconstr Surg Glob Open. 11(11): e5402, 2023. PMID38025610. PMC10653572.

4.         Baqai U., Kurimchak A.M., Trachtenberg I.V., Purwin T.J., Haj J.I., Han A., Luo K., Pachon N.F., Jeon A., Chua V., Davies M.A., Gutkind J.S., Benovic J.L., Duncan J.S., Aplin A.E., Kinome profiling identifies mark3 and stk10 as potential therapeutic targets in uveal melanoma. J Biol Chem. 299(12): 105418, 2023. PMID37923138.

5.         Behrens S., Lillemoe H.A., Dineen S.P., Russell M.C., Visser B., Berman R.S., Farma J.M., Grubbs E.,Davis J.L., Perceptions of readiness for practice after complex general surgical oncology fellowship: A survey study. Ann Surg Oncol, 2023. PMID37936022.

6.         Behrens S., Lillemoe H.A., Dineen S.P., Russell M.C., Visser B., Berman R.S., Farma J.M., Grubbs E.,Davis J.L., ASO visual abstract: Perceptions of readiness for practice after complex general surgical oncology fellowship: A survey study. Ann Surg Oncol, 2023. PMID38036928.

7.         Berg D., de Lima P.N., Knudsen A.B., Rutter C.M., Weinberg D., Lansdorp-vogelaar I.  NordICC trial results in line with expected colorectal cancer mortality reduction after colonoscopy: A modeling study. Gastroenterology. 165(4): 1077-1079 e2, 2023. PMIDWOS:001084550500001.

8.         Borghaei H., O’Byrne K.J., Paz-Ares L., Ciuleanu T.E., Yu X., Pluzanski A., Nagrial A., Havel L., Kowalyszyn R.D., Valette C.A., Brahmer J.R., Reck M., Ramalingam S.S., Zhang L., Ntambwe I., Rabindran S.K., Nathan F.E., Balli D.,Wu Y.L., Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: Results of the phase III checkmate 227 part 2 trial. ESMO Open. 8(6): 102065, 2023. PMID37988950.

9.         Broman K.K., Hughes T.M., Bredbeck B.C., Sun J., Kirichenko D., Carr M.J., Sharma A., Bartlett E.K., Nijhuis A.A.G., Thompson J.F., Hieken T.J., Kottschade L., Downs J., Gyorki D.E., Stahlie E., van Akkooi A., Ollila D.W., O’Shea K., Song Y., Karakousis G., Moncrieff M., Nobes J., Vetto J., Han D., Hotz M., Farma J.M., Deneve J.L., Fleming M.D., Perez M., Baecher K., Lowe M., Bagge R.O., Mattsson J., Lee A.Y., Berman R.S., Chai H., Kroon H.M., Teras J., Teras R.M., Farrow N.E., Beasley G.M., Hui J.Y.C., Been L., Kruijff S., Sinco B., Sarnaik A.A., Sondak V.K., Zager J.S.,Dossett L.A., International center-level variation in utilization of completion lymph node dissection and adjuvant systemic therapy for sentinel lymph node-positive melanoma at major referral centers. Ann Surg. 277(5): e1106-e1115, 2023. PMID35129464. PMC10097464.

10.       Camargo A.C., Constantino F.B., Santos S.A., Colombelli K.T., Portela L.M., Fioretto M.N., Barata L.A., Valente G.T., Moreno C.S., Justulin L.A., Deregulation of abcg1 early in life contributes to prostate carcinogenesis in maternally malnourished offspring rats. Mol Cell Endocrinol. 580: 112102, 2023. PMID37972683.

11.       Canepa E., Parodi-Rullan R., Vazquez-Torres R., Gamallo-Lana B., Guzman-Hernandez R., Lemon N.L., Angiulli F., Debure L., Ilies M.A., Østergaard L., Wisniewski T., Gutiérrez-Jiménez E., Mar A.C., Fossati S., FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness. Alzheimers Dement. 19(11): 5048-5073, 2023. PMID37186121. PMC10600328.

12.       Chanda A.K., Egleston B.L., Bai T., Vucetic S., Acm. Medcv: An interactive visualization system for patient cohort identification from medical claim data. in 31st ACM International Conference on Information and Knowledge Management (CIKM). 2022. Atlanta, GA.

13.       Daly M.B., Pal T., Maxwell K.N., Churpek J., Kohlmann W., Alhilli Z., Arun B., Buys S.S., Cheng H., Domchek S.M., Friedman S., Giri V., Goggins M., Hagemann A., Hendrix A., Hutton M.L., Karlan B.Y., Kassem N., Khan S., Khoury K., Kurian A.W., Laronga C., Mak J.S., Mansour J., McDonnell K., Menendez C.S., Merajver S.D., Norquist B.S., Offit K., Rash D., Reiser G., Senter-Jamieson L., Shannon K.M., Visvanathan K., Welborn J., Wick M.J., Wood M., Yurgelun M.B., Dwyer M.A., Darlow S.D., Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2024 featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network. 21(10): 1000-1010, 2023. WOS:001097901600007.

14.       Demetriadou C., Kantner D.S., Snyder N.W., Dietary branched-chain amino acids get to the heart of h3k23pr. J Clin Invest. 133(22)2023. PMID37966112.PMC10645384.

15.       Dudgeon C., Casabianca A., Harris C., Ogier C., Bellina M., Fiore S., Bernet A., Ducarouge B., Goldschneider D., Su X., Pitarresi J., Hezel A., De S., Narrow W., Soliman F., Shields C., Vendramini-Costa D.B., Prela O., Wang L., Astsaturov I., Mehlen P., Carpizo D.R., Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and elf3 signaling. Cell Rep. 42(11): 113369, 2023. PMID37922311.

16.       Enofe N., Garcia Russo M., Kadakia E.R., Axelrod P.I., Friedberg J., Su S., Kumar R., Mediastinal mass, cancer, or infection, atypical paraesophageal actinomycosis infection, clinical and surgical approach. Am Surg: 31348231211039, 2023. PMID38009532.

17.       Fernandez S.V., Tan Y.F., Rao S., Fittipaldi P., Sheriff F., Borghaei H., Dotan E., Winn J.S., Edelman M.J., Treat J., Judd J., Alpaugh R.K., Wang Y.L., Yu J.Q., Wasik M., Baldwin D.A., Validation of a molecular diagnostic test for circulating tumor DNA by next-gen sequencing. Int J Mol Sci. 24(21)2023. PMID37958763.PMC10648112.

18.       Flashner S., Shimonosono M., Tomita Y., Matsuura N., Ohashi S., Muto M., Klein-Szanto A.J., Diehl J.A., Chen C.H., Mochly-Rosen D., Weinberg K.I.,Nakagawa H., Aldh2 dysfunction and alcohol cooperate in cancer stem cell enrichment. Carcinogenesis, 2023. PMID37978873.

19.       Gomaa S., Lopez A., Slamon R., Smith R., Lapitan E., Nightingale G., Miller S.M.,Wen K.Y., The lived experience of patients with breast cancer on adjuvant endocrine therapy: Side effects and coping strategies during the first year of medication initiation. Support Care Cancer. 31(12): 719, 2023. PMID38008817.

20.       Harmange G., Hueros R.A.R., Schaff D.L., Emert B., Saint-Antoine M., Kim L.C., Niu Z., Nellore S., Fane M.E., Alicea G.M., Weeraratna A.T., Simon M.C., Singh A.,Shaffer S.M., Disrupting cellular memory to overcome drug resistance. Nat Commun. 14(1): 7130, 2023. PMID37932277.PMC10628298.

21.       Hu J., Hameed M.R., Agaram N.P., Whiting K.A., Qin L.X., Villano A.M., O’Connor R.B., Rozenberg J.M., Cohen S., Prendergast K., Kryeziu S., White R.L., Posner M.C., Socci N.D., Gounder M.M., Singer S., Crago A.M.  Pdgfrβ signaling cooperates with β-catenin to modulate c-abl and biologic behavior of desmoid-type fibromatosis. Clin Cancer Res, 2023. PMID37943631.

22.       Hurley M.F.D., Raddi R.M., Pattis J.G.,Voelz V.A., Expanded ensemble predictions of absolute binding free energies in the sampl9 host-guest challenge. Phys Chem Chem Phys, 2023. PMID38009066.

23.       Ji J., Bae M., Sun C.L., Wildes T.M., Freedman R.A., Magnuson A., O’Connor T., Moy B., Klepin H.D., Chapman A.E., Tew W.P., Dotan E., Fenton M.A., Kim H., Katheria V., Gross C.P., Cohen H.J., Muss H.B., Sedrak M.S., Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter hope trial. Cancer, 2023. PMID37962093.

24.       Jonasch E., Bauer T.M., Papadopoulos K.P., Plimack E.R., Merchan J.R., McDermott D.F., Dror Michaelson M., Appleman L.J., Roy A., Perini R.F., Liu Y., Choueiri T.K., Phase i litespark-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort. Eur J Cancer. 196: 113434, 2023. PMID38008031.

25.       Kantner D.S., Megill E., Bostwick A., Yang V., Bekeova C., Van Scoyk A., Seifert E., Deininger M.W., Snyder N.W., Comparison of colorimetric, fluorometric, and liquid chromatography-mass spectrometry assays for acetyl-coenzyme a. Anal Biochem. 685: 115405, 2023. PMID38016493.

26.       Khalil S., Olds A., Chin K., Erkmen C.P., Implementation of well-being for cardiothoracic surgeons. Thorac Surg Clin. 34(1): 63-76, 2024. PMID37953054.

27.       Krais J.J., Glass D.J., Chudoba I., Wang Y., Feng W., Simpson D., Patel P., Liu Z., Neumann-Domer R., Betsch R.G., Bernhardy A.J., Bradbury A.M., Conger J., Yueh W.T., Nacson J., Pomerantz R.T., Gupta G.P., Testa J.R., Johnson N., Genetic separation of brca1 functions reveal mutation-dependent polθ vulnerabilities. Nat Commun. 14(1): 7714, 2023. PMID38001070. PMC10673838.

28.       Liu Z.S., Sinha S., Bannister M., Song A., Arriaga-Gomez E., McKeeken A.J., Bonner E.A., Hanson B.K., Sarchi M., Takashima K., Zong D., Corral V.M., Nguyen E., Yoo J., Chiraphapphaiboon W., Leibson C., McMahon M.C., Rai S., Swisher E.M., Sachs Z., Chatla S., Stirewalt D.L., Deeg H.J., Skorski T., Papapetrou E.P., Walter M.J., Graubert T.A., Doulatov S., Lee S.C.,Nguyen H.D., R-loop accumulation in spliceosome mutant leukemias confers sensitivity to parp1 inhibition by triggering transcription-replication conflicts. Cancer Res, 2023. PMID37967363.

29.       Longacre M.L., Chwistek M., Keleher C., Siemon M., Egleston B.L., Collins M., Fang C.Y., Patient-caregiver portal system in palliative oncology: Assessment of usability and perceived benefit. JMIR Hum Factors. 10: e47624, 2023. PMID37917129.PMC10654898.

30.       Miller C., Bleicher R.J., Williams A.D., Breast cancer diagnosis, treatment, and outcomes of patients from sex and gender minority groups. Transl Cancer Res. 12(10): 2458-2460, 2023. PMID37969366.PMC10643937.

31.       Molli V.L.P., Kissa J., Baraniya D., Gharibi A., Chen T., Al-Hebshi N.N., Albandar J.M., Bacteriome analysis of aggregatibacter actinomycetemcomitans-jp2 genotype-associated grade c periodontitis in Moroccan adolescents. Front Oral Health. 4: 1288499, 2023. PMID38033462.PMC10682098.

32.       Movva S., Matloob S., Handorf E.A., Choy E., Merriam P., Flieder D.B., Cai K.Q., Zhou Y., Tetzlaff E.D., Pagan C., Barker E., Veggeberg R., Zumpano D., Rink L., von Mehren M.,George S., Sar-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (ddl), and leiomyosarcoma (lms). Clin Cancer Res, 2023. PMID37967116.

33.       Mulki R., Qayed E., Yang D., Chua T.Y., Singh A., Yu J.X., Bartel M.J., Tadros M.S., Villa E.C., Lightdale J.R., The 2022 top 10 list of endoscopy topics in medical publishing: An annual review by the American Society for Gastrointestinal Endoscopy editorial board. Gastrointest Endosc. 98(6): 1009-1016, 2023. PMID37977661.

34.       Oleinikov P.D., Fedulova A.S., Armeev G.A., Motorin N.A., Singh-Palchevskaia L., Sivkina A.L., Feskin P.G., Glukhov G.S., Afonin D.A., Komarova G.A., Kirpichnikov M.P., Studitsky V.M., Feofanov A.V.,Shaytan A.K., Interactions of nucleosomes with acidic patch-binding peptides: A combined structural bioinformatics, molecular modeling, fluorescence polarization, and single-molecule fret study. International Journal of Molecular Sciences. 24(20)2023. WOS:001089430400001. PMC10606924.

35.       Pang Y., Andargie T.E., Jang M.K., Kong H., Park W., Hill T., Redekar N., Fu Y.P., Parth D.A., Holtzman N.G., Pavletic S.Z., Agbor-Enoh S., Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA. iScience. 26(11): 108160, 2023. PMID38026221.PMC10651673.

36.       Papin C., Ibrahim A., Sabir J.S.M., Le Gras S., Stoll I., Albiheyri R.S., Zari A.T., Bahieldin A., Bellacosa A., Bronner C., Hamiche A., Mbd4 loss results in global reactivation of promoters and retroelements with low methylated cpg density. J Exp Clin Cancer Res. 42(1): 301, 2023. PMID37957685.PMC10644448.

37.       Paskett E.D., Battaglia T., Calhoun E.A., Chappell M.C., Dwyer A., Fleisher L.G., Greenwald J.,Wells K.J., Isn’t there enough evidence on the benefits of patient navigation? CA Cancer J Clin. 73(6): 562-564, 2023. PMID37358050.

38.       Portela L.M.F., Constantino F.B., Camargo A.C.L., Santos S.A.A., Colombelli K.T., Fioretto M.N., Barata L.A., Silva E.J.R., Scarano W.R., Felisbino S.L., Moreno C.S., Justulin L.A., Early-life origin of prostate cancer through deregulation of mir-206 networks in maternally malnourished offspring rats. Sci Rep. 13(1): 18685, 2023. PMID37907720.PMC10618455.

39.       Quinn C., Rico M.C., Merali C., Barrero C.A., Perez-Leal O., Mischley V., Karanicolas J., Friedman S.L.,Merali S., Secreted folate receptor γ drives fibrogenesis in metabolic dysfunction-associated steatohepatitis by amplifying tgfβ signaling in hepatic stellate cells. Science Translational Medicine. 15(715): eade2966, 2023. PMIDWOS:001082818900005.

40.       Robbins J., Halegoua-DeMarzio D., Basu Mallick A., Vijayvergia N., Ganetzky R., Lavu H., Giri V.N., Miller J., Maley W., Shah A.P., DiMeglio M., Ambelil M., Yu R., Sato T., Lefler D.S., Liver transplantation in a woman with mahvash disease. N Engl J Med. 389(21): 1972-1978, 2023. PMID37991855.

41.       Schaeffer E.M., Srinivas S., Adra N., An Y., Barocas D., Bitting R., Bryce A., Chapin B., Cheng H.H., D’Amico A.V., Desai N., Dorff T., Eastham J.A., Farrington T.A., Gao X., Gupta S., Guzzo T., Ippolito J.E., Kuettel M.R., Lang J.M., Lotan T., McKay R.R., Morgan T., Netto G., Pow-Sang J.M., Reiter R., Roach M., III, Robin T., Rosenfeld S., Shabsigh A., Spratt D., Teply B.A., Tward J., Valicenti R., Wong J.K., Shead D.A., Snedeker J.,Freedman-Cass D.A., Prostate cancer, version 4.2023. Journal of the National Comprehensive Cancer Network. 21(10): 1067-1096, 2023. PMIDWOS:001097901600014.

42.       Schmults C.D., Blitzblau R., Aasi S.Z., Alam M., Amini A., Bibee K., Bordeaux J., Chen P.L., Contreras C.M., DiMaio D., Donigan J.M., Farma J.M., Ghosh K., Harms K., Ho A.L., Lukens J.N., Mark L., Medina T., Nehal K.S., Nghiem P., Olino K., Park S., Patel T., Puzanov I., Rich J., Sekulic A., Shaha A.R., Srivastava D., Thomas V., Tomblinson C., Venkat P., Xu Y.G., Yu S., Yusuf M., McCullough B.,Espinosa S., Basal cell skin cancer, version 2.2024, NCCN Clinical Practice Guidelines in oncology. J Natl Compr Canc Netw. 21(11): 1181-1203, 2023. PMID37935106.

43.       Schober J.P., Wang R.,Kutikov A., Re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The role of (99m)tc-sestamibi single-photon emission computed tomography/computed tomography in the diagnostic pathway for renal masses: A systematic review and meta-analysis. Eur urol. In press. Https://doi.Org/10.1016/j.Eururo.2023.07.013. Eur Urol, 2023. PMID37977960. Letter.

44.       Serebriiskii I.G., Pavlov V.A., Andrianov G.V., Litwin S., Basickes S., Newberg J.Y., Frampton G.M., Meyer J.E., Golemis E.A.  Source, co-occurrence, and prognostic value of pten mutations or loss in colorectal cancer. NPJ Genom Med. 8(1): 40, 2023. PMID38001126.PMC10674024.

45.       Siminoff L.A., Wilson-Genderson M., West S.M., Hasz R.D., Suplee L., Clarke J., Barker K.L., Mulvania P.A.  Messaging White and Black next of kin in advance to promote authorization for tissue donation. Prog Transplant: 15269248231212922, 2023. PMID37946530.

46.       Sinko L., Ghazal L.V., Fauer A., Wheldon C.W.  It takes more than rainbows: Supporting sexual and gender minority patients with trauma-informed cancer care. Cancer, 2023. PMID38009962.

47.       Smit R.D., Ghosh B., Campion T.J., 3rd, Stingel R., Lavell E., Hooper R., Fan X., Soboloff J., Smith G.M., Stat3 protects dopaminergic neurons against degeneration in animal model of Parkinson’s disease. Brain Res. 1824: 148691, 2023. PMID38030102.

48.       Song Z., Wu W., Wei W., Xiao W., Lei M., Cai K.Q., Huang D.W., Jeong S., Zhang J.P., Wang H., Kadin M.E., Waldmann T.A., Staudt L.M., Nakagawa M.,Yang Y., Analysis and therapeutic targeting of the il-1r pathway in anaplastic large cell lymphoma. Blood. 142(15): 1297-1311, 2023. PMID37339580.PMC10613726.

49.       Sorscher S., LoPiccolo J., Heald B., Chen E., Bristow S.L., Michalski S.T., Nielsen S.M., Lacoste A., Keyder E., Lee H., Nussbaum R.L., Martins R., Esplin E.D., Rate of pathogenic germline variants in patients with lung cancer. JCO Precis Oncol. 7: e2300190, 2023. PMID37992258. PMC10681406.

50.       Swiecki-Sikora A.L., Lauder A., Harris A., Tagai E.K., Deng M., Jeronis S.L., Houck K.L., Miller S.M., Hernandez E., Attitudes about the human papillomavirus vaccine among patients with and without cervical dysplasia. J Low Genit Tract Dis, 2023. PMID37922471.

51.       Tangudu N.K., Huang Z., Fang R., Buj R., Uboveja A., Cole A.R., Happe C., Sun M., Gelhaus S.L., MacDonald M.L., Hempel N., Snyder N.W., Aird K.M., ATR promotes MTORC1 activation via de novo cholesterol synthesis in p16-low cancer cells. bioRxiv, 2023. PMID37961201. PMC10634888; PrePrint.

52.       Thomas K.K., Francescatti A.B., Vreeland T.J., Teshome M.K., Morris A.M., Hunt K.K., Katz M.H.G., Villano A.M., ASO visual abstract: Standardization of colon resection for cancer-an overview of the American College of Surgeons commission on cancer standard 5.6. Ann Surg Oncol, 2023. PMID37914924.

53.       Villamar-Cruz O., Loza-Mejía M.A., Vivar-Sierra A., Saldivar-Cerón H.I., Patiño-López G., Olguín J.E., Terrazas L.I., Armas-López L., Ávila-Moreno F., Saha S., Chernoff J., Camacho-Arroyo I.,Arias-Romero L.E., A ptp1b-cdk3 signaling axis promotes cell cycle progression of human glioblastoma cells through an rb-e2f dependent pathway. Mol Cell Biol: 1-19, 2023. PMID38014992.

54.       Wang Y., Zhu W., Jang Y., Sommers J.A., Yi G., Puligilla C., Croteau D.L., Yang Y., Kai M.,Liu Y., The RNA-binding motif protein 14 regulates telomere integrity at the interface of terra and telomeric r-loops. Nucleic Acids Res, 2023. PMID37930826.

55.       Wen K.Y., Dayaratna S., Slamon R., Granda-Cameron C., Tagai E.K., Kohler R.E., Hudson S.V., Miller S.M.  Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal pap test results in underserved urban women: A feasibility pilot study. Transl Behav Med, 2023. PMID38014626.

56.       Wiese W., Barczuk J., Racinska O., Siwecka N., Rozpedek-Kaminska W., Slupianek A., Sierpinski R., Majsterek I.  Pi3k/AKT/MTOR signaling pathway in blood malignancies-new therapeutic possibilities. Cancers (Basel). 15(21)2023. PMID37958470.PMC10648005.

57.       Williams A.D., Ruth K., Shaikh S.S., Vasigh M., Pronovost M.T., Aggon A.A., Porpiglia A.S., Bleicher R.J.  Should patients with hormone receptor-positive, her2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib? Cancer, 2023. PMID38018862.

58.       Xu K., Saaoud F., Shao Y., Lu Y., Jiang X., Wu S., Sun J., Fernades Conti F., Martinez L., Vazquez-Padron R., Wang H.,Yang X., Editorial: Debates in cardiovascular pharmacology and drug discovery: 2022. Front Cardiovasc Med. 10: 1304680, 2023. PMID37920177.PMC10619719.

59.       Yin J., Zenezan D., Doan K.D., Nobee A., Wei S., Mollaee M.,Proca D.M., Radiologic and clinicopathologic features of eosinophilic solid and cystic renal cell carcinoma: Report of two cases and review of literature. Int J Clin Exp Pathol. 16(10): 303-308, 2023. PMID37970333.PMC10641369.

60.       Yueh W.T., Glass D.J., Johnson N., Brca1 mouse models: Functional insights and therapeutic opportunities. J Mol Biol: 168372, 2023. PMID37979908.

61.       Zelenetz A.D., Gordon L.I., Abramson J.S., Advani R.H., Andreadis B., Bartlett N.L., Budde L.E., Caimi P.F., Chang J.E., Christian B., DeVos S., Dholaria B., Fayad L.E., Habermann T.M., Hamid M.S., Hernandez-Ilizaliturri F., Hu B., Kaminski M.S., Karimi Y., Kelsey C.R., King R., Krivacic S., LaCasce A.S., Lim M., Messmer M., Narkhede M., Rabinovitch R., Ramakrishnan P., Reid E., Roberts K.B., Saeed H., Smith S.D., Svoboda J., Swinnen L.J., Tuscano J., Vose J.M., Dwyer M.A.,Sundar H., Nccn guidelines® insights: B-cell lymphomas, version 6.2023. J Natl Compr Canc Netw. 21(11): 1118-1131, 2023. PMID37935098.

62.       Zhang X., Ali M., Pantuck M.A., Yang X., Lin C.R., Bahmed K., Kosmider B.,Tian Y., Cd8 t cell response and its released cytokine ifn-γ are necessary for lung alveolar epithelial repair during bacterial pneumonia. Front Immunol. 14: 1268078, 2023. PMID37954603.PMC10639165.

63.       Zhou Y., Börcsök J., Adib E., Kamran S.C., Neil A.J., Stawiski K., Freeman D., Stormoen D.R., Sztupinszki Z., Samant A., Nassar A., Bekele R.T., Hanlon T., Valentine H., Epstein I., Sharma B., Felt K., Abbosh P., Wu C.L., Efstathiou J.A., Miyamoto D.T., Anderson W., Szallasi Z.,Mouw K.W., Atm deficiency confers specific therapeutic vulnerabilities in bladder cancer. Sci Adv. 9(47): eadg2263, 2023. PMID37992168.PMC10664985.

Learn More

Fox Chase Cancer Center Staff Publication Database

Learn more about ORCID iDs

You may have been recently asked about your ORCID iD as part of an ongoing project or maybe a publisher asked for your id number while submitting a manuscript.  Maybe you’re just curious about what an ORCID iD is. Either way having an ORCID iD is a great way to represent yourself and your body of work online. 

Many researchers already have ORCID iDs but they haven’t updated or maintained them in a while.  Now is the perfect time to get your profile current and up to date.  Maintaining an accurate profile can help you promote your work, keep your bibliography current, and help you with writing grant proposals or your c.v.

If you need an ORCID iD or need help accessing your existing account here is some information that can help.

Getting an Orcid iD

First search for yourself in the ORCID database by searching your name on the ORCID home page to make sure you don’t already have an account.

If you don’t go to https://orcid.org/register to create an ORCID iD and fill out the form.

You will be asked to verify your email, once this is done your account is active and you can start to add things like your affiliation, versions of your name, email addresses etc.  Things that make it easy for people to know it’s your record.

Once you create an account you can sign in using various social sign ins like Google or Facebook.

You’ll also want to add works to your account so that your publications are always linked to you and the list is up to date.

Updating and maintaining your Orcid iD

First search for yourself in the ORCID database by searching your name on the ORCID home page.  If your name comes up and you are sure it is you, then you’ll find your iD number in the top left-hand corner of the page.  You can start editing your profile directly from this page by signing in.

If you created an ORCID account but have forgotten your password you can ask for a reset link.

I’m not sure I have an ORCID iD

First search for yourself in the ORCID database by searching your name on the ORCID home page. If your name comes up and you are sure it is you, then you’ll find your ID number in the top left-hand corner of the page.  You can start editing your profile directly from this page by signing in.

I have an ORCID iD but I can’t access it

If you created an ORCID account but have forgotten your password you can ask for a reset link.

If you created an ORCID account with an email you no longer use you can request help from ORCID

If you have an issue not discussed in this post please see the ORCID Help Center for assistance.

If you’re struggling with creating or updating your ORCID iD or any other author id reach out to the library. The Talbot Librarians are happy to help you with this and any other research need you may have. Call, stop by, or email us for assistance.

Learn More

• ORCID iD
• ORCID Help Center
• Talbot Library’s Author ID’s & Profiles Guide
• The Importance of Using Author IDs
• University of Missouri Library’s ORCID Registration Quick Start Guide

What Are Research Metrics?

Research metrics use quantitative tools to measure the value of research output (published articles) to the scientific community.  It can be used to evaluate authors, articles, or journals.  Research metrics include citation tracking, author h-index scores, and journal impact factors.  You may have seen these numbers in databases such as Web of Science.

In a very competitive field like scientific research these metrics can be the important and helpful.  They can be used to develop your career, help you on funding applications, and make it easier to find collaborators in your research field.

Citation Metrics

Citation metrics measures the impact of individual articles on the research community.  It tallies the number of times an article is cited by other researchers.  This is most often done by citation tracking.

Citation tracking calculates the number of times an article has been used in a published article.  This is good because it shows how important an article is to researchers.  The more times an article is used in published research articles the value of the article goes up.  This benefits authors by exposing your research to a broader audience. 

A low citation count doesn’t mean article has no value.  The article’s low visibility may come from the article being newly published, published in a less circulated journal, or not being indexed in a major database.  It could also be that the research topic is vary narrow and of interest to a specific field only.

This is why it is important to promote yourself and your work.  It also helps to make sure you are using tools to help your article find a broader audience.  Having a consistent personal identifier such as an author id can help make sure your articles are attributed properly.  Using standardized keywords and identifying high impact open access journals can help you grow your article’s visibility. 

Other aspects of promotion include using social media and being found on academic platforms like Research Gate or Google Scholar can help improve journal citation numbers.  You may also consider depositing your article in a scientific repository like PubMed Central or sharing your work on preprint repositories to generate interest in your work.

You can check your citation metrics on websites like Research Gate and Google Scholar as well as in subscription databases such as Web of Science. 

Author Metrics

Author metrics track the impact of the author or researcher’s work in the scientific community.  This metric also uses citation tracking but the distinction is it looks at the overall volume of an author’s work and creates a number based on the number of publications and the number of times cited.

The most well-known type of this type of metric is the h-index.  This information can be found in may subscription databases including Web of Science.  You can calculate your own h-index or ask the library to run a report for you.  Another type of author metrics is the i10-Index provided by Google Scholar.

Altmetrics

Altmetrics or “alternative metrics” measure the impact of an author’s work on social media by counting the times an article is shared on various social media sites.  It also measures pages views, PDF downloads, exports to bibliographic citation managers from publisher websites or databases.

These statistics are often displayed in graphical ways such as icons or badges.  Altmetric badges are becoming more and more popular on publisher websites and academic sharing sites such as Figshare.  Two major altmetric companies are Altmetric and PlumX.  

A great place to learn about metrics of all types is the Metrics Toolkit.  A free resource that details many types of metrics and how to use them.

Metrics can seem overwhelming, but the library is here to help.  Check out the library’s Scholarly Communication Guide to learn about author ids, predatory journals, and much more.  If you need more help then please contact the librarians to ask questions about citation metrics and other research related topics. 

Learn More

• Talbot Research Library Scholarly Communication Guide
• Talbot Research Library Web of Science H-Index Guide
• Preforming your own h-index searches
• Google Scholar
• Research Gate
• Altmetric
• PlumX
• Figshare
• Learn More about PubMed Central
• Metrics Toolkit

Staff Publications Received in October, 2023

1.         Ahn M.J., Cho B.C., Felip E., Korantzis I., Ohashi K., Majem M., Juan-Vidal O., Handzhiev S., Izumi H., Lee J.S., Dziadziuszko R., Wolf J., Blackhall F., Reck M., Bustamante Alvarez J., Hummel H.D., Dingemans A.C., Sands J., Akamatsu H., Owonikoko T.K., Ramalingam S.S., Borghaei H., Johnson M.L., Huang S., Mukherjee S., Minocha M., Jiang T., Martinez P., Anderson E.S.,Paz-Ares L., Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med, 2023. PMID37861218.

2.         Bandini L., Schatz A., Hood V., Clark N., Hall M.J., Carlson R.W., NCCN policy summit: Reducing the cancer burden through prevention and detection. Journal of the National Comprehensive Cancer Network. 21(9): 910-+, 2023. WOS:001079774300004.

3.         Bergerot C.D., Malhotra J., Bergerot P., Philip E.J., Castro D.V., Hsu J., Mota A., de Azeredo A.C., Neto J.N.D., Hutson T., Grünwald V., Bex A., Psutka S.P., Rini B., Plimack E.R., Master V., Albiges L., Choueiri T.K., Pal S., Powles T. Patients’ perceptions regarding the relevance of items contained in the functional assessment of cancer therapy kidney symptom index-19. Oncologist. 28(6): 494-500, 2023. WOS:001048007900022.

4.         Bevers T.B., Niell B.L., Baker J.L., Bennett D.L., Bonaccio E., Camp M.S., Chikarmane S., Conant E.F., Eghtedari M., Flanagan M.R., Hawley J., Helvie M., Hodgkiss L., Hoyt T.L., Ivanovich J., Jochelson M.S., Kulkarni S., Lancaster R.B., Mauer C., Maxwell J., Patel B.K., Pearlman M., Philpotts L., Plecha D., Plichta J.K., Shakeri S., Smith M.L., Streibert C.L., Strigel R.M., Tumyan L., Winkler N.S., Wolverton D.E., Bergman M.A., Kumar R., Stehman K., NCCN guidelines® Insights CE breast cancer screening and diagnosis, version 1.2023. Journal of the National Comprehensive Cancer Network. 21(9): 900-909, 2023. WOS:001079774300003.

5.         Borghaei H., de Marinis F., Dumoulin D., Reynolds C., Theelen W., Percent I., Calderon V.G., Johnson M.L., Madroszyk-Flandin A., Garon E.B., He K., Planchard D., Reck M., Popat S., Herbst R.S., Leal T.A., Shazer R.L., Yan X., Harrigan R., Peters S., Sapphire: Phase III study of sitravatinib plus nivolumab versus docetaxel in advanced non-squamous non-small cell lung cancer. Ann Oncol, 2023. PMID37866811.

6.         Choueiri T.K., Powles T., Voss M.H., Plimack E.R., Gurney H., Song Y., Perini R.F., Rodriguez-Lopez K., Rini B.I. Litespark-012: Pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma. Future Oncol, 2023. PMID37882432.

7.         Diefenbach M.A., Marziliano A., Tagai E.K., Pfister H., Lapitan E., Hall S.J., Vira M., Ibrahim S., Aibel K., Kutikov A., Horwitz E.M., Miyamoto C., Reese A.C., Miller S.M., Preference elicitation and treatment decision-making among men diagnosed with prostate cancer: Randomized controlled trial results of healium. J Med Internet Res. 25: e46552, 2023. PMID37862103.

8.         Dougherty T.P., Meyer J.E. Comparing lifestyle modifications and the magnitude of their associated benefit on cancer mortality. Nutrients. 15(9): 2038, 2023. doi:10.3390/nu15092038.

9.         Douglawi A., Ghoreifi A., Carbonara U., Yip W., Uzzo R.G., Margulis V., Ferro M., Cobelli O., Wu Z., Simone G., Mastroianni R., Rha K.H., Eun D.D., Reese A.C., Porter J.R., Derweesh I., Mehrazin R., Rosiello G., Tellini R., Jamil M., Kenigsberg A., Farrow J.M., Schrock W.P., Cacciamani G., Srivastava A., Bhattu A.S., Mottrie A., Gonzalgo M.L., Sundaram C.P., Abdollah F., Minervini A., Autorino R.,Djaladat H. Impact of variant histology on oncological outcomes in upper tract urothelial carcinoma: Results from the ROBUUST collaborative group. Clin Genitourin Cancer. 21(5): 563-568, 2023. PMID37301663.

10.       El Naggar A., Robins D., Baca Y., Arguello D., Ulm M., Arend R., Mantia-Smaldone G., Chu C., Winer I., Holloway R., Krivak T., Jones N., Galvan-Turner V., Herzog T.J., Brown J. Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy. Gynecol Oncol. 167(2): 306-313, 2022. PMID36229265.

11.       Epstein M., Helstrom E., Correa A., Balancing patient safety and early postoperative discharge: An American College of Surgeons national surgical quality improvement program analysis of postoperative complications after minimally invasive urologic surgery. J Urol: 101097ju0000000000003724, 2023. PMID37788014.

12.       Epstein M., Syed K., Danella J., Ginzburg S., Belkoff L., Tomaszewski J., Trabulsi E., Singer E.A., Jacobs B.L., Raman J.D., Guzzo T.J., Uzzo R., Reese A.C. Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: A cohort analysis of over 3000 men. Prostate Cancer Prostatic Dis, 2023. PMID37821578.

13.       Fiev D.N., Sirota E.S., Kozlov V.V., Proskura A.V., Shpot E.V., Chernenkiy M.M., Chernenkiy I.M., Puzakov K.B., Azil’gareeva K.R., Ismailov K.M., Butnaru D.V., Kutikov A., Vinarov A.Z., Correlation between 3d morphometric characteristics of kidney tumors and their histological structure. Onkourologiya. 19(2): 17-28, 2023. WOS:001054312300001.

14.       Fuller A.D., Whelan K.A., The underappreciated role of eosinophils in esophageal cancer. Cell Mol Gastroenterol Hepatol, 2023. PMID37839465.

15.       Gerson J.N., Handorf E., Villa D., Gerrie A.S., Chapani P., Li S., Medeiros L.J., Wang M.L., Cohen J., Churnetski M.C., Hill B.T., Sawalha Y., Hernandez-Ilizaliturri F.J., Kothari S.K., Vose J.M., Bast M.A., Fenske T.S., Narayana Rao Gari S., Maddocks K.J., Bond D.A., Bachanova V., Kolla B., Chavez J.C., Shah B.D., Lansigan F., Burns T.F., Donovan A., Wagner-Johnston N.D., Messmer M.R., Mehta A., Anderson J., Reddy N., Kovach A., Landsburg D.J., Glenn M.J., Inwards D.J., Ristow K., Karmali R., Kaplan J., Caimi P.F., Rajguru S.A., Evens A.M., Klein A.K., Umyarova E., Pulluri B., Amengual J.E., Lue J.K., Diefenbach C., Fisher R.I., Barta S.K., Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma. Blood Adv, 2023. PMID37874912.

16.       Gray Z.H., Chakraborty D., Duttweiler R.R., Alekbaeva G.D., Murphy S.E., Chetal K., Ji F., Ferman B.I., Honer M.A., Wang Z., Myers C., Sun R., Kaniskan H., Toma M.M., Bondarenko E.A., Santoro J.N., Miranda C., Dillingham M.E., Tang R., Gozani O., Jin J., Skorski T., Duy C., Lee H., Sadreyev R.I., Whetstine J.R., Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement. Cell. 186(21): 4528-4545.e18, 2023. PMID37788669. PMC10591855.

17.       Grunvald E., Wei J., Lin T., Yang K., Tu X.M., Lunde O., Ross E., Cheng J., DeConde J., Farber N., Exploring the effect of adding an interactive lecture to a standardized patient curriculum on the attitudes of third-year medical students about patients with obesity: A quasi-experimental study. J Med Educ Curric Dev. 10: 23821205231207683, 2023. PMID37854280. PMC10580723.

18.       Habib M.H., Schlögl M., Raza S., Chwistek M., Gulati A.  Interventional pain management in cancer patients-a scoping review. Ann Palliat Med, 2023. PMID37872129.

19.       Handorf E.A., Beck J.R., Correa A., Ramamurthy C., Geynisman D.M., Cost-effectiveness analysis for therapy sequence in advanced cancer: A microsimulation approach with application to metastatic prostate cancer. Med Decis Making: 272989×231201621, 2023. PMID37811793.

20.       Heinrich M.C., Corless C.L., Demetri G.D., Blanke C.D., von Mehren M., Joensuu H., McGreevey L.S., Chen C.J., Van den Abbeele A.D., Druker B.J., Kiese B., Eisenberg B., Roberts P.J., Singer S., Fletcher C.D.M., Silberman S., Dimitrijevic S., Fletcher J.A., Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol. 41(31): 4829-4836, 2023. PMID37890277.

21.       Im E.O., Chee W., Paul S., Choi M.Y., Kim S.Y., Deatrick J.A., Inouye J., Ma G., Meghani S., Nguyen G.T., Schapira M.M., Ulrich C.M., Yeo S., Bao T., Shin D.,Mao J.J., A randomized controlled trial testing a virtual program for Asian American women breast cancer survivors. Nat Commun. 14(1): 6475, 2023. PMID37838727.PMC10576740.

22.       Ioffe D., Dotan E., Evidence-based care of older adults with metastatic colorectal cancer: Insights from landmark clinical trials. J Clin Oncol: Jco2301337, 2023. PMID37856768.

23.       Leader A.E., Brandt H.M., Briant K.J., Curry G., Ellis K., Gonzalez E.T., Guerra C.E., Harding G., Hull P.C., Israel A., Melillo R., Mesia R.J., Schiffelbein J.E., Song Y., Surani Z., Tiro J.A., Vadaparampil S.T., Vanderpool R.C., Paskett E.D., Community outreach and engagement at U.S. Cancer centers: Notes from the 3rd cancer center community impact forum. Cancer Epidemiol Biomarkers Prev, 2023. PMID37791915.

24.       Lightle H.E., Kafley P., Lewis T.R., Wang R.E., Site-specific protein conjugates incorporating para-azido-l-phenylalanine for cellular and in vivo imaging. Methods. 219: 95-101, 2023. PMID37804961.

25.       Lundgren P., Sharma P.V., Dohnalová L., Coleman K., Uhr G.T., Kircher S., Litichevskiy L., Bahnsen K., Descamps H.C., Demetriadou C., Chan J., Chellappa K., Cox T.O., Heyman Y., Pather S.R., Shoffler C., Petucci C., Shalem O., Raj A., Baur J.A., Snyder N.W., Wellen K.E., Levy M., Seale P., Li M., Thaiss C.A., A subpopulation of lipogenic brown adipocytes drives thermogenic memory. Nat Metab. 5(10): 1691-1705, 2023. PMID37783943.

26.       Marziliano A., Miller S.M., Fleisher L.G., Ropka M.E., Stanton A.L., Wen K.Y., Cornelius T., Lapitan E., Diefenbach M.A., Examining the impact of a multimedia intervention on decisional conflict and psychological distress among early-stage breast cancer patients: Results from a nationwide rct. Transl Behav Med. 13(10): 727-735, 2023. PMID37379519.PMC10538468.

27.       Neelapu S.S., Chavez J.C., Sehgal A., Epperla N., Ulrickson M.L., Bachy E., Munshi P., Casulo C., Maloney D.G., de Vos S., Reshef R., Leslie L.A., Oluwole O.O.D., Yakoubagha I., Khanal R., Rosenblatt J.D., Korn R., Peng W., Lui C., Wullf J., Shen R.R., Poddar S., Jung A.S., Miao H., Beygi S., Jacobson C.A., Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-hodgkin lymphoma (zuma-5). Blood, 2023. PMID37879047.

28.       Nigam A., Hurley M.F.D., Li F., Konkoĭová E., Klíma M., Trylčová J., Pollice R., Çinaroǧlu S.S., Levin-Konigsberg R., Handjaya J., Schapira M., Chau I., Perveen S., Ng H.L., Ümit Kaniskan H., Han Y., Singh S., Gorgulla C., Kundaje A., Jin J., Voelz V.A., Weber J., Nencka R., Boura E., Vedadi M., Aspuru-Guzik A., Drug discovery in low data regimes: Leveraging a computational pipeline for the discovery of novel sars-cov-2 nsp14-mtase inhibitors. bioRxiv, 2023. PMID37873443. PMC10592886. (Preprint)

29.       Oleinikov P.D., Fedulova A.S., Armeev G.A., Motorin N.A., Singh-Palchevskaia L., Sivkina A.L., Feskin P.G., Glukhov G.S., Afonin D.A., Komarova G.A., Kirpichnikov M.P., Studitsky V.M., Feofanov A.V., Shaytan A.K., Interactions of nucleosomes with acidic patch-binding peptides: A combined structural bioinformatics, molecular modeling, fluorescence polarization, and single-molecule fret study. Int J Mol Sci. 24(20)2023. PMID37894874. PMC10606924.

30.       Peyton S.R., Platt M.O., Cukierman E., Challenges and opportunities modeling the dynamic tumor matrisome. BME Front. 4: 0006, 2023. PMID37849664.PMC10521682.

31.       Pivirotto A.M., Platt A., Patel R., Kumar S., Hey J., Analyses of allele age and fitness impact reveal human beneficial alleles to be older than neutral controls. bioRxiv, 2023. PMID37873438. PMC10592680.

32.       Pook D., Geynisman D.M., Carles J., de Braud F., Joshua A.M., Pérez-Gracia J.L., Llácer Pérez C., Shin S.J., Fang B., Barve M., Maruzzo M., Bracarda S., Kim M., Kerloeguen Y., Gallo J.D., Maund S.L., Harris A., Huang K.C., Poon V., Sutaria D.S., Gurney H., A phase Ib, open-label study evaluating the safety and efficacy of ipatasertib plus rucaparib in patients with metastatic castration-resistant prostate cancer. Clin Cancer Res. 29(17): 3292-3300, 2023. PMID37339186.

33.       Price A.D., Foote D.C., Woeste M.R., Winer L.K., Montgomery K.B., Al Yafi M., Nahmias J.T., Postlewait L.M., Sutton J.M., Quillin R.C., Cortez A.R., Defining the disparity: A multi-institutional analysis of factors associated with decreased resident operative experience. J Surg Res. 293: 647-655, 2023. PMID37837821.

34.       Pruthi D.K., Miller G., Ankerst D.P., Neumair M., Capitanio U., Correa A.F., Lane B.R., Roussel E., McGregor T.B., Derweesh I.H., Cordeiro M., Pierorazio P.M., Calvo C., Bi H., Noyes S.L., Meagher M., Kutikov A., Uzzo R.G., Van Poppel H., Larcher A., Montorsi F., Kattan M.W., Kaushik D., Liss M.A., Reply by authors. J Urol. 210(5): 761-762, 2023. PMID37811759.

35.       Rodgers-Fouche L., Arora S., Ricker C., Li D., Farooqi M., Balaguer F., Dominguez-Valentin M., Guillem J.G., Kanth P., Liska D., Melson J., Mraz K.A., Shirts B.H., Vilar E., Katona B.W., Hodan R., Exploring stakeholders’ perspectives on implementing universal germline testing for colorectal cancer: Findings from a clinical practice survey. JCO Precis Oncol. 7: e2300440, 2023. PMID37897815.

36.       Sanft T., Day A., Ansbaugh S., Armenian S., Baker K.S., Ballinger T., Demark-Wahnefried W., Dickinson K., Fairman N.P., Felciano J., Flores T.F., Friedman D.L., Gabel N.M., Goldman M., Henry N.L., Hill-Kayser C., Hudson M., Koura D., Lee K., McDonough A.L., Melisko M., Mooney K., Moore H.C.F., Moryl N., Neuman H., O’Connor T., Overholser L., Paskett E.D., Patel C., Peterson L., Pirl W., Porpiglia A., Rodriguez M.A., Schapira L., Schwartz A.L., Smith S., Tevaarwerk A., Yang E.R., Zee P., McMillian N.R.,F reedman-Cass D.A., Survivorship, version 1.2023 featured updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 21(8): 792-803, 2023. WOS:001063796600005.

37.       Schwartzberg L., Navari R.M., Ruddy K.J., LeBlanc T.W., Clark-Snow R., Wickham R., Kloth D., Binder G., Bailey W.L., Turini M., Potluri R., Liu X., Papademetriou E.,Roeland E.J., Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis. Support Care Cancer. 31(12): 654, 2023. PMID37878086.PMC10600031.

38.       Seeger C., A crispr-based system to investigate HBV cccDNA biology. J Virol. 97(10): e0118523, 2023. PMID37819132.PMC10617570.

39.       Singla K., Vempuluru V.S., Ehya H., Shields C.L., Iridociliary metastasis from cryptic cutaneous melanoma simulating primary uveal melanoma. Can J Ophthalmol, 2023. PMID37863108.

40.       Sit Y.T., Takasaki K., An H.H., Xiao Y., Hurtz C., Gearhart P., Zhang Z., Gadue P., French D., Chou S.T., Synergistic roles of dyrk1a and gata1 in trisomy 21 megakaryopoiesis. JCI Insight, 2023. PMID37906251.

41.       Snyder R.A., Burtness B., Cho M., Del Rivero J., Doroshow D.B., Hitchcock K.E., Kalyan A., Kim C.A., Lukovic J., Parikh A.R., Sanford N.N., Singh B., Shen C., Shroff R.T., Vijayvergia N., Goodman K.A., Kunz P.L., The room where it happens: Addressing diversity, equity, and inclusion in national clinical trials network clinical trial leadership. J Natl Cancer Inst. 115(10): 1132-1138, 2023. PMID37364007.

42.       Thomas K.K., Francescatti A.B., Vreeland T.J., Teshome M.K., Morris A.M., Hunt K.K., Katz M.H.G., Villano A.M., Standardization of colon resection for cancer: An overview of the American College of Surgeons commission on cancer standard 5.6. Ann Surg Oncol, 2023. PMID37880516.

43.       Topchu I., Bychkov I., Gursel D., Makhov P., Boumber Y., Nsd1 supports cell growth and regulates autophagy in hpv-negative head and neck squamous cell carcinoma. bioRxiv, 2023. PMID37786686.PMC10541623. (Preprint)

44.       Uzzo R., Bex A., Pal S.K., Authors’ reply. Lancet. 402(10397): 181-181, 2023. WOS:001081489900001.

45.       Uzzo R., Bex A., Pal S.K., The value of immotion010 for rare kidney cancer histologies reply. Lancet. 402(10397): 181-182, 2023.  WOS:001081489900002.

46.       Uzzo N., Loecher M., Uzzo R.G. ,Eun D.D., A sheep in wolf’s clothing; a case of renal leiomyoma masquerading as hereditary leiomyomatosis and renal cell carcinoma. Urol Case Rep. 51: 102567, 2023. PMID37818410. PMC10561035.

47.       van den Berg D.M.N., Nascimento de Lima P., Knudsen A.B., Rutter C.M., Weinberg D., Lansdorp-Vogelaar I., NordICC trial results in line with expected colorectal cancer mortality reduction after colonoscopy: A modeling study. Gastroenterology. 165(4): 1077-1079.e2, 2023. PMID37454978.

48.       Van Houtven C.H., Miller K.E.M., James H.J., Blunt R., Zhang W., Mariani A.C., Rose S., Alolod G.P., Wilson-Genderson M., Smith V.A., Thomson M.D., Siminoff L.A., Economic costs of family caregiving for persons with advanced stage cancer: A longitudinal cohort study. J Cancer Surviv, 2023. PMID37823982.

49.       Walmer R.W., Ritter V.S., Sridharan A., Kasoji S.K., Altun E., Lee E., Olinger K., Wagner S., Radhakrishna R., Johnson K.A., Rathmell W.K., Qaqish B., Dayton P.A.,Chang E.H., The performance of flash replenishment contrast-enhanced ultrasound for the qualitative assessment of kidney lesions in patients with chronic kidney disease. J Clin Med. 12(20)2023. PMID37892632.PMC10607866.

50.       Wang X., Liu L., Jiang X., Saredy J., Xi H., Cueto R., Sigler D., Khan M., Wu S., Ji Y., Snyder N.W., Hu W., Yang X., Wang H., Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer’s disease. Alzheimers Res Ther. 15(1): 164, 2023. PMID37789414. PMC10546779.

51.       Wang Y., He S., Calendo G., Bui T., Tian Y., Lee C.Y., Zhou Y., Zhao X., Abraham C., Mo W., Chen M., Sanders-Braggs R., Madzo J., Issa J.J., Hexner E.O., Wiest D.L., Reshef R., Xue H.H., Zhang Y., Tissue-infiltrating alloreactive t cells require id3 to deflect PD-1-mediated immune suppression during gvhd. Blood, 2023. PMID37871574.

52.       Waraksa-Deutsch T.L., Leading medical laboratory professionals toward change readiness: A correlational study. Lab Med, 2023. PMID37788447.

53.       Yang Y., Johnson J., Troupes C.D., Feldsott E.A., Kraus L., Megill E., Bian Z., Asangwe N., Kino T., Eaton D.M., Wang T., Wagner M., Ma L., Bryan C., Wallner M., Kubo H., Berretta R.M., Khan M., Wang H., Kishore R., Houser S.R., Mohsin S. Mir-182/183-rasa1 axis induced macrophage polarization and redox regulation promotes repair after ischemic cardiac injury. Redox Biol. 67: 102909, 2023. PMID37801856.PMC10570148.

54.       Zhu L., Dodd S.J., Chen Y., Kaminsky E.R., Liu Z.E., Ma G.X., Ogunwobi O.O., Fang C.Y., Educating the next generation of cancer researchers: Evaluation of a cancer research partnership training program. PLoS One. 18(10): e0286279, 2023. PMID37792689.PMC10550190.

Learn More

Fox Chase Cancer Center Staff Publication Database

Importing ClinicalTrials.gov Citations Into Endnote X20

Want to import citation information from clinicaltrials.gov into your Endnote Library?  It’s easy to do, once you do a little setup in advance.  After the set up you will find it easy to import clinical data into your Endnote Library.

Here are the steps to get you started:

First you will need to download the Clinical Trial filter from Endnote.

• Go to https://endnote.com/filter_download/clinicaltrials/ and download the filter

This is the Endnote Clinical Trials filter.

Then you will need to move it to the correct folder

• On your computer go to your hard drive and locate the Endnote 20 folder
• Open the folder and find the Filters folder
• Copy the .enf file to this folder
• Once the filter is in the filter folder you can select it in Endnote when you import your clinicaltrials.gov data

Now do your search

• Got to ClinicalTrials.gov and do a search
• Select the trials you want to bring into Endnote
• Select Download, Plain Text, All available Columns and start the download
• In Endnote
• Select File, Import, File
• Select the file from clinicaltrials.gov you downloaded, select other filters, and look for the filter called ClinicalTrials, select choose, then select OK
• Your download should be imported into Endnote

This is the ClinicalTrials.gov download window.

The references will be imported as generic references you may want to change the reference type to website.  Find the citation open it up and use the dropdown list next to Reference Type to change it to website.

The USC Library has an amazing video that shows the process in real time so you can follow along.

If you have any trouble installing the filter or want to learn more about using Endnote call, email, or stop by the library.  Don’t forget about the library’s Endnote Guide it has a wealth of information on using Endnote.

Learn More

• Clinical Trial Filter from Endnote
• Clinical Trials.gov
• Talbot Research Library Endnote Guide
• USC Library Video Clinicaltrials.gov Citation Export for Endnote Software

Publications Received in September, 2023

1.         Andreeva T.V., Maluchenko N.V., Efremenko A.V., Lyubitelev A.V., Korovina A.N., Afonin D.A., Kirpichnikov M.P., Studitsky V.M., Feofanov A.V., Epigallocatechin gallate affects the structure of chromatosomes, nucleosomes and their complexes with parp1. Int J Mol Sci. 24(18)2023. PMID37762491.PMC10532227.

2.         Aquino A.M., Alonso-Costa L.G., Santos S.A.A., Rocha V.A., Barbisan L.F., Bedrat A., Justulin L.A., Flaws J.A., Lemos B., Scarano W.R., Integrated transcriptome and proteome analysis indicates potential biomarkers of prostate cancer in offspring of pregnant rats exposed to a phthalate mixture during gestation and lactation. Chemosphere. 341: 140020, 2023. PMID37690569.

3.         Bandini L., Schatz A., Hood V., Clark N., Hall M.J., Carlson R.W., NCCN policy summit: Reducing the cancer burden through prevention and early detection. J Natl Compr Canc Netw. 21(9): 910-914.e1, 2023. PMID37673113.

4.         Barham D.W., Simhan J., Yafi F.A., Gross M.S., An approach to the thoughtful selection of antimicrobial prophylaxis for inflatable penile prosthesis surgery. J Sex Med. 20(9): 1140-1142, 2023. PMID37655674.

5.         Barta J.A., Erkmen C.P., Shusted C.S., Myers R.E., Saia C., Cohen S., Wainwright J., Zeigler-Johnson C., Dako F., Wender R., Kane G.C., Vachani A., Rendle K.A., The Philadelphia lung cancer learning community: A multi-health-system, citywide approach to lung cancer screening. JNCI Cancer Spectr, 2023. PMID37713466.

6.         Bevers T.B., Niell B.L., Baker J.L., Bennett D.L., Bonaccio E., Camp M.S., Chikarmane S., Conant E.F., Eghtedari M., Flanagan M.R., Hawley J., Helvie M., Hodgkiss L., Hoyt T.L., Ivanovich J., Jochelson M.S., Kulkarni S., Lancaster R.B., Mauer C., Maxwell J., Patel B.K., Pearlman M., Philpotts L., Plecha D., Plichta J.K., Shakeri S., Smith M.L., Streibert C.L., Strigel R.M., Tumyan L., Winkler N.S., Wolverton D.E., Bergman M.A., Kumar R., Stehman K., NCCN Guidelines® Insights: Breast cancer screening and diagnosis, version 1.2023. J Natl Compr Canc Netw. 21(9): 900-909, 2023. PMID37673117.

7.         Cheng N.H., Li Y., Cheng G., Metastatic pulmonary calcification on bone scintigraphy of a patient with lupus nephritis and end-stage renal disease. Radiol Case Rep. 18(11): 3993-3996, 2023. PMID37691761. PMC10491819.

8.         Clevenger M.H., Karami A.L., Carlson D.A., Kahrilas P.J., Gonsalves N., Pandolfino J.E., Winter D.R., Whelan K.A., Tétreault M.P., Suprabasal cells retain progenitor cell identity programs in eosinophilic esophagitis-driven basal cell hyperplasia. JCI Insight. 8(19)2023. PMID37672481.

9.         Daniel O., Ashrafi A., Muthoni M.A., Njoki N., Eric H., Marilynn O., Faith A.B., Beth W.G., Nyakio M., Odero-Marah V., Ragin C. , Llanos A.A.M., Delayed breast cancer presentation, diagnosis, and treatment in Kenya. Breast Cancer Res Treat, 2023. PMID37668821.

10.       Del Rivero J., Perez K., Kennedy E.B., Mittra E.S., Vijayvergia N., Arshad J., Basu S., Chauhan A., Dasari A.N., Bellizzi A.M., Gangi A., Grady E., Howe J.R., Ivanidze J., Lewis M., Mailman J., Raj N., Soares H.P., Soulen M.C., White S.B., Chan J.A., Kunz P.L., Singh S., Halfdanarson T.R., Strosberg J.R., Bergsland E.K. Systemic therapy for tumor control in metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO guideline. J Clin Oncol: Jco2301529, 2023. PMID37774329.

11.       Drzewiecka M., Jaśniak D., Barszczewska-Pietraszek G., Czarny P., Kobrzycka A., Wieczorek M., Radek M., Szemraj J., Skorski T., Śliwiński T., Class I hdac inhibition leads to a downregulation of fancd2 and rad51, and the eradication of glioblastoma cells. J Pers Med. 13(9)2023. PMID37763083.PMC10532614.

12.       Efe G., Dunbar K.J., Sugiura K., Cunningham K., Carcamo S., Karaiskos S., Tang Q., Cruz-Acuna R., Resnick-Silverman L., Peura J., Lu C., Hasson D., Klein-Szanto A.J., Taylor A.M., Manfredi J.J., Prives C., Rustgi A.K., P53 gain-of-function mutation induces metastasis via brd4-dependent csf-1 expression. Cancer Discov, 2023. PMID37676642.

13.       Ettinger D.S., Wood D.E., Stevenson J., Aisner D.L., Akerley W., Bauman J.R., Bharat A., Bruno D.S., Chang J.Y., Chirieac L.R., DeCamp M., Dilling T.J., Dowell J., Durm G.A., Gettinger S., Grotz T.E., Gubens M.A., Hegde A., Lackner R.P., Lanuti M., Lin J., Loo B.W., Lovly C.M., Maldonado F., Massarelli E., Morgensztern D., Mullikin T.C., Ng T., Otterson G.A., Patel S.P., Patil T., Polanco P.M., Riely G.J., Riess J., Shapiro T.A., Singh A.P., Tam A., Tanvetyanon T., Yanagawa J., Yang S.C., Yau E., Gregory K.M., Hughes M.  Mesothelioma: Peritoneal, version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 21(9): 961-979, 2023. PMID37673108.

14.       Filchner K., Zoucha R., Lockhart J.S., Denlinger C.S., Empowering lung cancer survivors in post-treatment survivorship care using participatory action research. Oncol Nurs Forum. 50(5): 563-575, 2023. PMID37677759.

15.       Fleisher L., Kenny C., Rusten C., Koren D., Landau Z. Correction to: Right information, right patient, right time: Utilizing the mycarecompass platform to deliver patient education in the oncology setting. J Cancer Educ, 2023. PMID37707651.

16.       Ghatalia P., Plimack E.R. Harnessing potent therapies with care: Enfortumab vedotin plus pembrolizumab for advanced-stage urothelial carcinoma. Nat Rev Clin Oncol, 2023. PMID37667009.

17.       Golan T., Casolino R., Biankin A.V., Hammel P., Whitaker K.D., Hall M.J., Riegert-Johnson D.L., Germline brca testing in pancreatic cancer: Improving awareness, timing, turnaround, and uptake. Ther Adv Med Oncol. 15: 17588359231189127, 2023. PMID37720496.PMC10504836.

18.       Gross S., Womer L., Kappes D.J., Soboloff J.  Multifaceted control of t cell differentiation by stim1. Trends Biochem Sci, 2023. PMID37696713.

19.       Hernandez N.E., Jankowski W., Frick R., Kelow S.P., Lubin J.H., Simhadri V., Adolf-Bryfogle J., Khare S.D., Dunbrack R.L., Jr., Gray J.J.,Sauna Z.E., Corrigendum to “computational design of nanomolar-binding antibodies specific to multiple sars-cov-2 variants by engineering a specificity switch of antibody 80r using rosettaantibodydesign (rabd) results in potential generalizable therapeutic antibodies for novel sars-cov-2 virus” [heliyon 9(4) (april 2023) e15032]. Heliyon. 9(8): e17901, 2023. PMID37701412.PMC10493423.

20.       Hsu R., Chen D., Xia B., Feldman R., Cozen W., Raez L.E., Borghaei H., Kim C., Nagasaka M., Mamdani H., Vanderwalde A.M., Lopes G., Socinski M.A., Wozniak A.J., Spira A.I., Liu S.V., Nieva J.J., Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer. Front Oncol. 13: 1215524, 2023. PMID37700839.PMC10494442.

21.       Jan R., Huang M. ,Lewis-Wambi J. Retraction note: Loss of pigment epithelium-derived factor: A novel mechanism for the development of endocrine resistance in breast cancer. Breast Cancer Res. 25(1): 107, 2023. PMID37726770.PMC10508022.

22.       Kaplan J., Lee Z.H., Grome L., Yao C.M.K.L., Mericli A.F., Roubaud M.S., Largo R.D., Garvey P.B., Sensory outcomes for inferior alveolar nerve reconstruction with allograft following free fibula mandible reconstruction. Plast Reconstr Surg. 152(3): 499e-506e, 2023. PMID36780351.

23.       Kaur J., Vijayvergia N. Narrative review of immunotherapy in gastroentero-pancreatic neuroendocrine neoplasms. Curr Oncol. 30(9): 8653-8664, 2023. PMID37754542.PMC10527684.

24.       Kim P.M., Nejati R., Lu P., Thakkar D., Mackrides N., Dupoux V., Nakhoda S., Baldwin D.A., Pei J., Dave S.S., Wang Y.L., Wasik M. Leukemic presentation and progressive genomic alterations of mcd/c5 diffuse large b-cell lymphoma (dlbcl). Cold Spring Harb Mol Case Stud, 2023. PMID37730436.

25.       Klaus C.A., Henry K.A., Il’yasova D.  Capturing emergency dispatch address points as geocoding candidates to quantify delimited confidence in residential geolocation. Int J Health Geogr. 22(1): 25, 2023. PMID37752482.PMC10523746.

26.       Lee R.A., Kutikov A.  Pathological and clinical outcomes in a large surveillance and intervention cohort of radiographically cystic renal masses. Reply. Journal of Urology. 210(3): 408-410, 2023.  

27.       Lu Y., Sun Y., Saaoud F., Shao Y., Xu K., Jiang X., Wu S., Yu J., Snyder N.W., Yang L., Shi X.M., Zhao H., Wang H., Yang X.  Er stress mediates angiotensin ii-augmented innate immunity memory and facilitates distinct susceptibilities of thoracic from abdominal aorta to aneurysm development. Front Immunol. 14: 1268916, 2023. PMID37731512.PMC10507336.

28.       Maluchenko N.V., Korovina A.N., Saulina A.A., Studitsky V.M., Feofanov A.V.  [the role of the wgr domain in the functions of parp1 and parp2]. Mol Biol (Mosk). 57(5): 782-791, 2023. PMID37752643.

29.       Mann-Barnes T., Bhimla A., Coronado M., Lin T., Duro-Aina A., Park H., Ma G.X.  Factors that predict HPV vaccination behavior among young men-who-have-sex-with-men in the greater Philadelphia region. J Racial Ethn Health Disparities. 10(5): 2167-2174, 2023. PMID36036840.PMC9422934.

30.       Midya A., Hiremath A., Huber J., Sankar Viswanathan V., Omil-Lima D., Mahran A., Bittencourt L.K., Harsha Tirumani S., Ponsky L., Shiradkar R., Madabhushi A., Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: Preliminary findings. Front Oncol. 13: 1166047, 2023. PMID37731630.PMC10508842.

31.       Mohsin S., Wang H., Khan M., Inflammation attenuating lncrnas in diabetic cardiomyopathy. Mol Ther Nucleic Acids. 34: 102029, 2023. PMID37766794.PMC10520423.

32.       Nejati R., Neumann-Domer R., Liu Z., Koslosky L., Neumann-Domer E., Pei J., Wang Y.L., Testa J.R.  Isochromosome 7p, i(7)(p10): A rare aml, myelodysplasia-related entity. Leuk Res Rep. 20: 100387, 2023. PMID37701905.PMC10493252.

33.       Okyere A.D., Nayak T.K., Patwa V., Teplitsky D., McEachern E., Carter R.L., Xu H., Gao E., Zhou Y., Tilley D.G.  Myeloid cell-specific deletion of epidermal growth factor receptor aggravates acute cardiac injury. Clin Sci (Lond). 137(19): 1513-1531, 2023. PMID37728308. NEEDS PMCID.

34.       Plimack E.R., Powles T., Stus V., Gafanov R., Nosov D., Waddell T., Alekseev B., Pouliot F., Melichar B., Soulières D., Borchiellini D., McDermott R.S., Vynnychenko I., Chang Y.H., Tamada S., Atkins M.B., Li C., Perini R., Rhoda Molife L., Bedke J., Rini B.I.  Corrigendum to “pembrolizumab plus axitinib versus sunitinib as first-line treatment of advanced renal cell carcinoma: 43-month follow-up of the phase 3 keynote-426 study” [eur. Urol. (2023)]. Eur Urol. 84(5): e123-e124, 2023. PMID37666734.

35.       Quinn C., Rico M.C., Merali C., Barrero C.A., Perez-Leal O., Mischley V., Karanicolas J., Friedman S.L., Merali S.  Secreted folate receptor γ drives fibrogenesis in metabolic dysfunction-associated steatohepatitis by amplifying tgfβ signaling in hepatic stellate cells. Sci Transl Med. 15(715): eade2966, 2023. PMID37756380.

36.       Roldan L., Montoya C., Solanki V., Cai K.Q., Yang M., Correa S., Orrego S., A novel injectable piezoelectric hydrogel for periodontal disease treatment. ACS Appl Mater Interfaces. 15(37): 43441-43454, 2023. PMID37672788.

37.       Rosser B.R.S., Weideman B.C.D., Rider G.N., Jatoi A., Ecklund A.M., Wheldon C.W., Talley K.M.C., Kulasingam S., Smith M.K., Jacobs D.R., Mitteldorf D., West W., Alley R., Ross M.W.  Sexual and gender minority invisibility in cancer studies: A call for effective recruitment methods to address cancer disparities. J Clin Oncol: Jco2300655, 2023. PMID37725780.

38.       Schober J.P., Ginsburg K.B., Kutikov A., Cho E.Y., Loecher M., Strauss D., Castro Bigalli A.A., Handorf E., Deng M., Anaokar J., Chen D.Y.T., Greenberg R.E., Smaldone M.C., Viterbo R., Correa A.F., Uzzo R.G., Strother M.  Real-time estimation of nephron activity with a linear measurement system (renal-ms) predicts postoperative estimated glomerular filtration rate. BJU Int, 2023. PMID37667554.

39.       Schweke H., Xu Q., Tauriello G., Pantolini L., Schwede T., Cazals F., Lhéritier A., Fernandez-Recio J., Rodríguez-Lumbreras L.A., Schueler-Furman O., Varga J.K., Jiménez-García B., Réau M.F., Bonvin A., Savojardo C., Martelli P.L., Casadio R., Tubiana J., Wolfson H.J., Oliva R., Barradas-Bautista D., Ricciardelli T., Cavallo L., Venclovas Č., Olechnovič K., Guerois R., Andreani J., Martin J., Wang X., Terashi G., Sarkar D., Christoffer C., Aderinwale T., Verburgt J., Kihara D., Marchand A., Correia B.E., Duan R., Qiu L., Xu X., Zhang S., Zou X., Dey S., Dunbrack R.L., Levy E.D., Wodak S.J.  Discriminating physiological from non-physiological interfaces in structures of protein complexes: A community-wide study. Proteomics. 23(17): e2200323, 2023. PMID37365936.

40.       Ubba V., Joseph S., Awe O., Jones D., Dsilva M.K., Feng M., Wang J., Fu X., Akbar R.J., Bodnar B.H., Hu W., Wang H., Yang X., Yang L., Yang P., Ahima R., Divall S.,Wu S., Neuronal ar regulates glucose homeostasis and energy expenditure in lean female mice with androgen excess. Endocrinology. 164(11)2023. PMID37738624.

41.       Vaidya R., Unger J.M., Qian L., Minichiello K., Herbst R.S., Gandara D.R., Neal J.W., Leal T.A., Patel J.D., Dragnev K.H., Waqar S.N., Edelman M.J., Sigal E.V., Adam S.J., Malik S., Blanke C.D., LeBlanc M.L., Kelly K., Gray J.E., Redman M.W.  Representativeness of patients enrolled in the lung cancer master protocol (lung-map). JCO Precis Oncol. 7: e2300218, 2023. PMID37677122.

42.       Wang Y., Risteski P., Yang Y., Chen H., Droby G., Walens A., Jayaprakash D., Troester M., Herring L., Chernoff J., Tolić I.M., Bowser J., Vaziri C.  The trim69-mst2 signaling axis regulates centrosome dynamics and chromosome segregation. Nucleic Acids Res, 2023. PMID37739411.

43.       Watson R.J., Caba A.E., Lawrence S.E., Renley B.M., McCauley P.S., Wheldon C.W., Eaton L.A., Russell S.T., Eisenberg M.E.  Examining mental health and bullying concerns at the intersection of sexuality, gender, race, and ethnicity among a national sample of sexual and gender diverse youth. LGBT Health, 2023. PMID37668602.

44.       Wilt J.K., Siminoff L.A., Thomson M.D.  Pre-diagnosis symptoms, attributed causes, and healthcare seeking assets of younger colorectal cancer survivors. J Cancer Educ, 2023. PMID37715897.

45.       Wong S.J., Torres-Saavedra P.A., Saba N.F., Shenouda G., Bumpous J.M., Wallace R.E., Chung C.H., El-Naggar A.K., Gwede C.K., Burtness B., Tennant P.A., Dunlap N.E., Redman R., Stokes W.A., Rudra S., Mell L.K., Sacco A.G., Spencer S.A., Nabell L., Yao M., Cury F.L., Mitchell D.L., Jones C.U., Firat S., Contessa J.N., Galloway T., Currey A., Harris J., Curran W.J., Jr., Le Q.T. Radiotherapy plus cisplatin with or without lapatinib for non-human papillomavirus head and neck carcinoma: A phase 2 randomized clinical trial. JAMA Oncol, 2023. PMID37768670.PMC10540060. 46.       Zhang Q., Basappa J., Wang H.Y., Nunez-Cruz S., Lobello C., Wang S., Liu X., Chekol S., Guo L., Ziober A., Nejati R., Shestov A., Feldman M., Glickson J.D., Turner S.D., Blair I.A., Van Dang C., Wasik M.A.  Chimeric kinase alk induces expression of nampt and selectively depends on this metabolic enzyme to sustain its own

Evidence-Based Practice (Nursing) New LibGuide

The Talbot Research Library is proud to announce a new subject guide developed especially for nursing and clinical staff who are interested in doing evidenced-based practice research. 

This guide which is called the Evidence Based Practice (Nursing) Guide has information on applying Evidence-based Practice research techniques such as the the IOWA Model for clinical care research and creating PICO questions.

Fox Chase staff can also get access to the IOWA model tools and templates (use your Temple Health login) as well as list of books and resources found in the Talbot Research Library to help with your research.

Don’t forget if you need research assistance, want a literature search, or have any questions about starting your research you can reach out to the library. The librarians are always happy to help.

Call, email or stop by the library to discuss your research projects with the Talbot Library’s talented librarians. 

Learn More

• Evidence Based Practice (Nursing) Guide
• Evidence Based Medicine Guide
• Talbot Research Library Homepage
• Request a literature search form